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INTRODUCTION 
In most countries where pigs are agriculturally important, reports on 
industrial problems and research indicate that respiratory disease is an 
economically significant problem. The most common respiratory disease of 
pigs is mycoplasmal pneumonia. It has been estimated that 40-50 percent 
of all pigs are affected with mycoplasmal pneumonia (Switzer, 1969). 
Mycoplasmal pneumonia of pigs has been responsible for substantial 
economic loss, and has a worldwide distribution. Mycoplasma hyopneumoniae 
was shown to be the causal agent (Mare and Switzer, 1965). The chronic 
mycoplasmal pneumonia occurs mostly in young pigs between 3 and 10 weeks 
of age. There are many workers that have already reported the clinical 
signs and pathologic lesions, with complete details of the disease. 
Mycoplasmal pneumonia is described as a chronic, low mortality, high 
morbidity disease of swine characterized by coughing, loss of vigor, " 
growth retardation, and decreased efficiency of food utilization. 
Livingston et al. (1972) completely described the histopathological change 
of the lung post inoculation of M. hyopneumoniae. They noted the first 
change was small lymphoid nodules extending through the alveolar area. 
Gross lesions became evident at the 14th day post infection and consisted 
of lymphocytic cells and inflamatory exudate within bronchi and alveoli. 
The greatest severity of the microscopic lesions occurred between 22 to 38 
days and included lymphoid hyperplasia and severe damage of alveoli. The 
severity of the microscopic lesion is mild after 42nd day post infection. 
Livingston and co-workers also reported the loss of cilia over the 
bronchial epithelial cells. The extensive microscopic damage of the 
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alveolar area by M. hyopneumoniae could lead to the physiological 
alteration of the respiratory system. 
The lung is a vital organ for gas exchange. Many workers have 
studied the nature of the interface between air and alveolar tissue. 
Clements et al. (1961) described the surface phenomena in relation to 
pulmonary function and showed the importance of the film lining the 
alveolar surface. Mammalian lungs contain a specialized acellular lining 
material with surface active properties that stabilize the pulmonary 
alveoli against collapse (Clements et al., 1958). A film of this surfac­
tant material has characteristic properties in which the dynamic surface 
tension decreases sharply as the surface area is decreased and increases 
sharply as the surface area is increased. The phospholipids are the major 
component of the pulmonary surfactant secreted from the type II alveolar 
epithelial cells as demonstrated by Macklin (1954), Scarpelli (1968b), and 
Heinemann and Fishman (1969). There are several pathological conditions 
that alter the secretion of pulmonary surfactant and subsequently the gas 
exchange. 
This study was undertaken to measure physiological and hematological 
changes in the pigs with induced mycoplasmal pneumonia. Two experiments 
were conducted. The first experiment was designed to study the changes of 
respiratory parameters such as volume, expansibility (elasticity), 
ventilatory ability (inspiratory and expiratory velocity), and the 
arterial blood gas measurements on the 4th, 5th and 6th week post inocu­
lation of hyopneumoniae. Studies of hematological changes were made 
in order to assess the pathologic condition of the disease. The pulmonary 
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surfactant was collected by lung lavage for chemical analysis. The second 
experiment was designed to study the phospholipid synthesis at the 4th and 
5 t h  w e e k  p o s t  i n f e c t i o n  b y  i n t r a v e n o u s  i n j e c t i o n  o f  p a l  m i  t a  t e - a n d  t o  •  
determine the radioactivity in the lung as well as in pulmonary surfac­
tant. 
In addition, the pigs are now considered to be useful as an animal 
model for research in human respiratory disease because pigs have sub­
mucosal glands which compare closely in degree of development and distri­
bution with those of man (Goco et al., 1963). Since the young children 
also suffered from pneumonia which is caused by a virulent Mycoplasma 
pneumoniae, it is possible that the information on the physiological and 
hematological changes in mycoplasma pneumonia of pigs could be used for 
comparative studies in man. 
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REVIEW OF LITERATURE 
The Mycoplasmal Pneumonia of Swine 
The disease has been referred to as swine enzootic pneumonia (SEP) or 
virus pneumonia of pigs (VPP) and has been described as the most wide­
spread and economically important swine disease in the world (Betts, 1952; 
Young, 1964). The prevalence of mycoplasmal pneumonia of swine has been 
estimated to vary from 34 to 74 percent (Betts, 1952; Young and Underdahl, 
1955; Young and Underdahl, 1960). The disease has no special seasonal 
occurrence. 
Mare and Switzer (1965) and Goodwin et al. (1965) demonstrated that 
the causative agent of this disease in not viral but a mycoplasmal organ­
ism. Mare and Switzer (1965) reported the isolation and propagation in 
cell-free fluid and solid mediums of an agent capable of eliciting the 
pneumonia in 80 to 100 percent of the inoculated respiratory disease-free 
pigs. They showed that the causative agent of the disease was a Myco­
plasma sp. and named it Mycoplasma hyopneumoniae. This finding has been 
confirmed in Canada by L'Ecuyer (1969), in Japan by Takatori (1969), in 
England by Roberts (1968) and by Hodges et al. (1969). 
Goodwin et al. (1965) were able to grow a mycoplasma which induced a 
enzootic pneumonia. They named it Mycoplasma suipneumoniae (Goodwin et 
al., 1967). However, because the cultures of M. hyopneumoniae and M. 
suipneumoniae were indistinguishable by the growth inhibition and 
metabolic inhibition test, Edward and Freundt (1969) suggested that the 
species designation of hyopneumoniae has priority over suipneumoniae and 
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should be used to designate the causative agent of the chronic mycoplasmal 
pneumonia of swine. Mare (1965) estimated that the organism is between 
110 mu and 225 mu in diameter. Observation of Giemsa stained preparation 
revealed coccoid and cocco-bacillary bodies with occasional ring forms. 
Mycoplasmal pneumonia is spread from one pig to another by direct 
contact or by inhalation of airborne Mycoplasma. Young pigs usually con­
tact the pneumonia from their mothers (Young, 1964). At the present time 
there is no effective treatment for mycoplasmal pneumonia of swine. 
Several of the broad spectrum antibiotics such as chlortetracycline and 
oxytetracycline will suppress development of the pneumonic lesion if the 
animal is receiving a drug at the time of exposure. Sulfonamides, peni­
cillin, and streptonycin have been reported as useless in treatment by 
Betts (1952). 
Mare (1965) and Livingston et al. (1972) studied the details of the 
macroscopic lesions of mycoplasmal pneumonia. Histologic changes were 
found in the lungs on the 6th post inoculation day. The gross lesion can 
be found in the lung of infected pigs at the 14th day post inoculation. 
The lesions are found predominantly in the apical, cardiac, and inter­
mediate lobes of the lung, and the left cardiac and left apical lobes are 
affected less frequently. The frequency and location of lesions in the 
different lobes of the lungs can be attributed to the mechanical barrier 
produced by the walls of the trachea and bronchi. The gross lesions 
developed to maximal severity between the 21st and 28th days and then they 
regressed. The mycoplasmal pneumonia is histologically characterized by 
clearly demarcated, reddish-blue to light pinkish-grey colored lesions in 
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the affected lobes. Microscopic lesions consist of alveolar interstitial 
thickening, giant cell formation, neutrophil infiltration, septal cell 
proliferation, and peribronchiolar and perivascular lymphoid hyperplasia. 
Pattison (1956) and Jericho (1968) suggested that there are several agents 
that can result in grossly similar lesions. 
The humoral immunity 
Lannek and Bomfors (1957) showed that a strong immunity developed in 
experimentally induced pneumonia. Pigs were infected, allowed to recover 
and then challenged 118 days after the primary infection. All the chal­
lenged pigs were free from enzootic pneumonia at slaughter, whereas all of 
the positive controls had pneumonia. 
Roberts (1968) was able to detect antibodies to M. hyopneumoniae in 
pig serum by using the standard complement fixation (CF) test. Boulanger 
and L'Ecuyer (1968) also demonstrated antibodies to the organism at two to 
three weeks after experimental injection by the use of a modified direct 
complement fixation test. The antibodies remained detectable for more 
than 200 days. Boulanger and L'Ecuyer were also able to demonstrate 
antibodies by an indirect CF test but the titer obtained was lower than 
that measured with the modified test. Takatori (1969) also demonstrated 
CF antibodies in pigs experimentally infected with M. hyopneumoniae. He 
also reported that anitbodies first appeared two to three weeks after 
inoculation. Goodwin et al. (1969) detected CF antibodies in pigs in­
fected with M. hyopneumoniae and found no correlation between either the 
extent of the pneumonic lesions or the immune state and the titer obtained. 
They also successfully employed an indirect hemagglutination test for the 
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detection of antibodies against M. hyopneumoniae. They also found that 
pigs which had recovered from the disease were strongly immune to chal­
lenge and no lung lesions developed when the animals were inoculated with 
lung suspensions that produced extensive lesions of enzootic pneumonia in 
control animals. 
Lam and Switzer (1971) developed an indirect hemagglutination (IHA) 
test for the detection of antibodies to M. hyopneumoniae in swine._ They 
showed that in serum of pigs with naturally occurring infection antibodies 
were detected in 68 to 87 (78.1%) pigs having macroscopic pneumonic lesions 
and in 56 of 82 (68.2%) pigs not having lesions. They did a serologic test 
of 433 swine serum samples from various field herds, and found antibodies 
against M. hyopneumoniae. Two hundred ninety-one of the sera were 
positive (67.2%). Lam (1970) showed that by using an indirect hemag­
glutination (IHA) test for the detection of M. hyopneumoniae infection, 
pigs injected with the agent developed antibodies two to three weeks post 
infection and maintained that level for 130 days. The level of antibody 
started to fall off gradually after that, but remained detectable for at 
least 320 days post-infection. He also reported that the healthy pigs in 
contact with pigs that had just been injected with live culture of M. 
hyopneumoniae developed antibody titers in five to six weeks. When sus­
ceptible pigs were in contact with pigs that had been injected two months 
previously, the susceptible pigs developed antibody in seven to eight 
weeks but failed to develop lung lesions. 
At the present time the complement-fixation test is the best tech­
nique available for the epidemiologic investigation of mycoplasmal 
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pneumonia of swine. However, the conventional complement-fixation test 
for M. hyopneumoniae antibodies, considered satisfactory as a herd test, 
is not reliable for the serum samples from individual pigs. The older 
pigs inoculated with ^ hyopneumoniae did not produce a positive M. 
hyopneumoniae complement fixation reaction as reported by Robert and 
Little (1970). Slavik and Switzer (1972) modified the method of micro-
titration complement-fixation. This method can detect the antibody of 
experimentally infected pigs as early as two weeks post-infection and as 
long as 24 weeks post-infection. The sensitivity of the CF test was in­
creased greatly by heating the test sera at 56°C for 30 minutes and by 
using normal, unheated swine serum as the reconstituting fluid for the 
lyophilized guinea pig complement. Slavik and Switzer reported that this 
technique can detect antibodies to M. hyopneumoniae at dilution of test 
sera as low as 1:8 and no complement-fixation cross-reactions were ob­
served among other mycoplasmal species. Switzer and Preston (1974) used 
this micro-complement-fixation test for the large number of pigs with a 
wide range of age in Iowa. They found that the highest percent of in­
fected pigs were pigs less than one year of age. 
Robert (1973) reported observations on the cell-mediated immune 
response to M. hyopneumoniae, as measured by macrophage migration inhibi­
tion, the pigs infected with the organism also gave a positive intradermal 
reaction within 24 hours following inoculation. However, the control and 
infected pigs used in both the intradermal and macrophage migration inhi­
bition tests were in small number. These methods could be used as a reli­
able diagnostic aid but require more research. 
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The Surfactant Systems of the Lung 
The term "surfactant" refers to a substance which is surface active. 
The phrase "pulmonary surfactant" is used to denote the substance respon­
sible for the unusually great surface activity present in mammalian lungs. 
There are many physiological studies indicating that extremely low surface 
tension (i.e., 10 dynes/cm or lower) must be present within the air-filled 
lung when it is at a low volume. It is observed that a lung does not 
collapse completely when very low distending pressures are present. 
Alveolar surface tension, especially at low lung volumes, would become 
high and the alveoli would be apt to collapse unless the surface forces of 
the air-tissue interface could be stabilized. In 1929, Von Neergard was 
the first to postulate that a stabilizing substance must be present in the 
lung. He demonstrated the effects of surface forces on the pressure-
volume characteristics of excised lung. Macklin (1954) reported that the 
mucoid film on alveolar wall performs vital functions, such as assisting in 
the removal of fine lining or dead particulate matters, the maintenance of 
a constant favorable alveolar surface tension, the facilitation of gaseous 
exchange, the protection of the underlying tissue from desiccation, and 
the suppression of invading microorganisms. He also suggested that the 
film of the alveolar wall is secreted by granular pneumocytes. The pre­
liminary studies showed that the alveolar lung fluid forms an insoluble 
film at an air-liquid interface and modifies the surface tension of this 
interface in a manner which depends on alveolar surface area (Rattle, 
1958; Clements et al., 1958; Avery and Mead, 1959). Clements et al. 
(1958) showed the effects of surface tension on lung mechanics and postu­
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lated that this interfacial material would reduce the pressure acting 
across the alveolar interface and thereby prevent the collapse of the 
easily distensible alveolar units. In the higher mammals, the numerous 
alveoli provide the air-liquid interface of very large surface area. 
Scarpelli (1968b) has termed this material, because of its complex 
chemical nature, "the pulmonary surfactant system." 
The cellular origin of pulmonary surfactant 
There are two types of cells occurring on the alveolar side of the 
basement membrane: Type I alveolar epithelial cells are very thin averag­
ing 0.5 y in thickness and type II alveolar cells are round and large 
ranging from <10 to 15 y in thickness. The alveolar surface of the epi­
thelial cells particularly the surface of the type II cell that possesses 
microvilli, is rough. There are two layers of the acellular materials as 
shown by functional difference. The outside film facing the alveolar air 
is composed of densely spaced, highly surface-active phospholipids which 
are recruited from the underlying hypophase during expansion of the lungs 
and may reenter the hypophase at low lung volumes as described by Pattle 
(1965). The second layer is the base layer or the hypophase as described 
by Scarpelli (1968b). Electron microscopic and histologic studies by 
Bensch et al. (1964) and Kikkawa et al. (1965) have demonstrated that 
the inclusion bodies of type II cells are secretory. Naden (1967) 
reported that the inclusion bodies of the type II alveolar cell contain 
a surface active substance and are removed from the alveolar surface 
by phagocytosis. He proposed that the nonciliated, or Clara cells of 
the bronchioles synthesize the surfactant. His evidence was histochemical 
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studies which showed the phospholipid in Clara cells and autoradiographs 
which were interpreted as showing localization of primary precursor in 
Clara cells as soon as 5 minutes after injection. 
Autoradiographs by Buckingham et al. (1966) used tritium labeled 
palmitate and acetate. They found labeled grains over the cytoplasm 
of granular pneumocytes near but not over the inclusion vacuoles. Askin 
and Kuhn (1971) injected tritiated palmitate into rats. By autoradio­
graphy and thin layer chromatography they found that there was progressive 
incorporation of labeled fatty acid into lecithin from 5 minutes to 4 
hours after injection with much less incorporation into other lipid 
classes. Autoradiographs showed consistently heavier labeling of alveolar 
cells than of Clara cells. Electron microscopy demonstrated that the 
label was localized in the cytoplasm of granular pneumocites and was most 
concentrated over the osmiophillic inclusions. This experiment indicated 
that granular pneumocytes are a major source of alveolar lecithin. 
Massaro and Massaro (1972) incubated the amino acid leucine-4, with 
rat lung slices and used morphometric methods to determine the location of 
The lungs that were removed 4 minutes after the addition of leucine 
showed 70% of the grains in type II cells to be above the rough endoplasmic 
reticulum and 10% to be over the lamellar bodies. By 40 minutes after the 
injection the relationship had changed so that 56% of the grains were over 
the rough endoplasmic reticulum and 29% over the lamellar bodies. 
Chevalier and Collett (1972) reported similar studies with mouse lung but 
they used three potential precursors of the surfactant: choline-^H, 
leucine-^H, and galactose-^H. Between 30 and 120 minutes after injection 
of any of the three precursors, the number of grains over the lamellar 
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bodies increased relative to the number of grains elsewhere. According 
to Page-Roberts (1972) the lamellar bodies contain a high ratio of 
phospholipid to protein and the phospholipid is the surface active 
material. Kikkawa et al. (1975) used a method for isolation of type II 
alveolar epithelial cells which yield 95% purity. By using radiolabeled 
studies they showed that the isolated type II cells synthesized disatu­
rated lecithin predominantly through the cytidine diphosphocholine path­
way. The ^'•C-choline incorporation into di saturated lecithin was three 
times as active in type II cells as in macrophages. The rate of surfac­
tant metabolism is rapid, as calculated from studies with radioactive 
precursors of dipalmitoyl lecithin (Tierney et al., 1967). They found 
that the biological half-life of radioactivity was approximately 14 hours 
in rat. They also pointed out that the short half-life of saturated 
lecithin is concordant with the rate of turnover of surface-active alveolar 
lining calculated from observations of alveolar instability. Pawlowski et 
al. (1971) injected 'H-palmitâte dissolved alcohol into dogs and then 
removed lungs at intervals during the next 6 hours. They extracted their 
surface-active fraction from both the lavage material and from lung. 
Their results showed the half-life in the lung is 5 hours, and the 
specific activity of phosphatidyl choline in the lavage material did not 
reach that activity in the residual lung. Young and Tierney (1972) 
injected palmitate-l-i'^C into rats, and determined the specific activity 
of dipalmitoyl phosphatidyl lecithin (DPL) in the lung tissue and in the 
fluid removed by a lung lavage. They found that the specific activities 
of DPL in the lung tissue and lavage fluid did not demonstrate a simple 
precursor-product type of relationship, since the DPL in lavage fluid has 
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a higher specific activity at 8 hours but not at 48 and 72 hours after 
the injection, and the decreasing specific activity of DPL in lung tissue 
did not follow a single exponential change with time. 
Chemical composition of pulmonary surfactant 
There are many techniques for determining the composition of the 
surfactant. The lavage technique and centrifugation are currently used 
for surfactant separation. The utilization of isolated cell population 
enriched in type II alveolar cells (Kikkawa et al., 1975) and fractionated 
by the methods of Gil and Reiss (1973) may ultimately provide the most 
unambiguous results. 
Galdston et al. (1969) isolated a highly surface active fraction in 
the sediment of cell-free lung wash of excised rabbit lung by a simple 
centrifugation technique. They found that the sediment consists of about 
60% lipid (lecithin) and 40% protein by weight. Of the lipid, about 90% 
is phospholipid and 10% nonphospholipid. By gas-liquid chromatography, 
the total fatty acids of the lipid tnoiety were found to be equally dis­
tributed among saturated and unsaturated acids. Frosolono et al. (1970) 
studied the chemistry of a surface-active fraction from dog lung. They 
found that the fraction contained lipid, protein, and carbohydrate, and 
the predominant lipid present was dipalmi toy! phosphatidyl choline. In 
1971 Pfleger and Thomas studied the lipid composition of the surfactant 
and the exfoliated lining cells in normal beagle dog lungs. They found 
that phospholipids accounted for more than 70% of the surfactant and 
phosphatidyl choline was the predominant phosphatide. Phosphatidyl 
glycerol is present in beagle dog pulmonary surfactant (10% of Phospho­
lipid), in exfoliated lining cells (7% of phospholipid), and in lung 
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tissue (3% of phospholipid). Body (1971) reported the phospholipid com­
position of pig lung surfactant, and found that pulmonary surfactant 
contained 80% lipid material, 1.5% phosphatidyl glycerol, 2.0% lyso-bis-
phosphatidic acid. 
Pfleger et al. (1972) isolated and characterized a phosphatidyl 
glycerol from pulmonary surfactant lipids of beagle dogs. They reported 
that phosphatidyl glycerol accounts for 10% of the surfactant phospholipid 
and was at least as surface active as lecithin. King (1974) classified 
the lipid composition of surface-active fractions obtained from the lung 
into three groups: a) unfractionated lung and lavage fluid (Group A), b) 
fractions isolated by relatively simple techniques, generally employing 
one or two steps of centrifugation of physiological saline (Group B, and 
c) fraction isolated by more involved techniques including differential 
centrifugation (Group C). Abrams (1966) isolated the lipoprotein from the 
homogenates of mammalian lungs. This lipoprotein can lower surface tens-
si on to 3 dynes/Cm or less at a surface area of 20 cm^. He also reported 
that the lung of babies who died of hyaline membrane disease contained 
less than 1/10th the amount of surface-active lipoprotein in normal infant 
lung. Clements (1970) pointed out that the composition and the physiolog­
ical importance of the protein found in surface-active material have been 
difficult to assess. The lipoprotein isolated from rabbit lung wash was 
shown by immunologic techniques to have come from lung and not from blood 
(Galdston et al., 1969). Galdston and Shah (1970) reported that the 
association between lipid and protein appears to be of the Van der Walls 
type, and lipoprotein showed the high surface properties. However, 
Scarpelli et al. (1967) analyzed the pulmonary surfactant from dog and 
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rabbit lung and observed no lipoprotein complex. By using several methods 
for surfactant extraction such as Abrams (1966), Klein and Margolis (1968) 
and Galdston et al. (1969), Scarpelli et al. (1971) proved that the surfac­
tant was not a lipoprotein complex. Klein and Margolis (1968) purified the 
pulmonary surfactant from rabbit lung by ultracentrifugation. They found 
that the surface active materials include protein. Colacicco et al. (1973) 
studied the protein in the lavage from rabbit lungs. They separated the 
pulmonary washing from rabbit lungs into four fractions by gel filtration 
through Sephadex G-200. The void volume fraction contains 87% of the 
phospholipid and most of two proteins designated S and T. These proteins 
can be separated from each other by centrifugation at 49,000 x g for 1 
hour. The protein S together with over 60% of the phospholipid, is found 
in the pellet while protein T is found in the supernatant. King et al. 
(1973) isolated the protein components of canine surface active material 
obtained by lung lavage. They identified three electrophoretically and 
imnunologieaMy distinct proteins. Two proteins with molecular weights 
of about 11,000 and 34,000 daltons comprise most of the material with a 
relatively small amount of a 69,000 dalton protein. Immunologic analysés 
suggest that the 69,000 daltons component is albumin, while the 34,000 and 
11,000 dalton proteins are unidentified but are not derived from serum. 
King et al. (1975) studied the time of appearance of apoprotein in 
amniotic fluid by an agglutination immunoassay. They found that the 
apoprotein was first detected at 30 to 32 weeks of gestation, and its 
concentration increased almost fivefold to a maximum at 37 weeks. At all 
gestational ages there was wide variability in both phospholipid and 
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apoprotein concentrations, and the time of appearance of the apoprotein 
in amniotic fluid differed among fetuses. They also found that the 
presence of surfactant apoprotein in amniotic fluid is coincident with 
the biochemical and morphological maturation of the fetal lung and this 
protein is cosecreted with the lipids of surface active materials. 
Pulmonary surfactant and lung maturation 
The mammalian lung undergoes changes late in gestation that are 
essential for the newborn infant to survive. Brumley et al. (1967) 
studied the development of lung at 120 to 130 days in lamb and found that 
phospholipid and percent saturated fatty acids on phosphatidyl choline 
were relatively constant from 60 to 120 days gestational age; thereafter 
there was a significant increase in both measurements. The trigger for 
lung maturation is a result of the effect of steroids upon the fetal lung. 
Liggins (1969) observed that hydrocortisone infusion into the fetal lamb 
led to premature delivery and these prematurely born lambs were viable at 
an earlier gestational age than lambs that had not received the steroids. 
Kontas and Avery (1971) injected a single dose of 9-f1uoropredni sol one 
intramuscularly and intraamniotically at 24 days of gestation in a rabbit. 
At 26 or 27 days, in injected fetuses, the lungs were more mature than 
expected at that age, as reflected in the surface tension of lung extracts 
and pressure-volume curves. Wang et al. (1971) histologically studied the 
rabbit lung by injection of 9-fluoroprednisolone into 24 day rabbit 
fetuses. They found that the steroid induced accelerated maturation of 
the alveolar lining cells and at 26 or 27 days gestation, there was in­
creased formation of osmiophillic bodies in type II alveolar cells and 
abundant osmiophillic material in the alveolar spaces. The alveolar cells 
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at this time were similar in appearance to those of 28 and 29 day control 
fetuses. There are receptors for steroids present in the fetal lung in 
greater quantity per unit mass than in any other organ. The receptors 
bind the steroid and probably transport it to active sites within the 
cells (Ballard and Ballard, 1972). Adams and Fujiwara (1963) reported 
that the immature lamb lacked surface activity in the tracheal fluid, 
whereas the mature fetus had detectable surfactant in the tracheal fluid. 
It appeared that the surfactant enters the amniotic fluid of the mature 
fetus. Scarpelli (1968b) was the first who indicated the importance of 
amniotic fluid studies to estimate the lung maturity. Gluck et al. (1971) 
developed the method to predict the respiratory distress syndrome in the 
newborn. The infant mortality and the respiratory distress syndrome are 
closely related to lung immaturity and probably to inadequate surfactant 
secretion. Gluck observed that during maturation the lung has little 
change in sphingomyelin content but a great increase in saturated phospha­
tidyl choline. By this observation it can be assumed that the lecithin 
and sphingomyelin in the amniotic fluid would be determined largely by the 
secretion of surfactant from the lung. Gluck et al. (1971) established 
the ratio between lecithin/sphingomyelin in the amniotic fluid for pre­
diction of the respiratory distress syndrome of the newborn. They con­
cluded that if a ratio of 1.5 or lower is present in amniotic fluid 
within 24 hours of birth, a high incidence of respiratory distress syn­
drome occurs. In contrast, if the lecithin/sphingomyelin ratio is above 
2.0 a low incidence of respiratory distress syndrome occurs. The measure­
ment on amniotic fluid can therefore be used to predict the respiratory 
distress syndrome if the fetus is delivered within the next 24 hours. 
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This method is supported by the report of Blumenfeld et al. (1974). 
These observations also suggested that lung immaturity with inadequate 
secretion of saturated phosphatidyl choline causes respiratory distress 
syndrome. 
Glycoprotein 
A great number of the proteins that are found in nature have carbo­
hydrate covalently linked to the peptide portion and are termed glycopro­
teins. These conjugate proteins are represented by many substances of 
biologic importance, including enzymes, hormones, antibodies and mem­
branes. The collagens, major structural proteins of the body, have now 
been clearly shown to belong to the glycoprotein family, and a large 
number of carbohydrate-containing proteins are present in plasma and 
mucous secretion. Glycoproteins have no unique amino acid composition, 
but do contain carbohydrates such as D-mannose, D-glucose, L-fucose, D-
xylose- N-acetyl-D-glucosamine and the various derivatives of neuramimic 
acid (the sialic acids). The carbohydrate content of glycoproteins may 
vary from less than 1 percent to more than 80 percent of the weight of the 
molecule, and as few as two to as many as seven sugar types may be present 
in a given glycoprotein (Spiro, 1963). 
Many of the plasma proteins that play a part in transport have been 
shown to be glycoproteins, including ceruloplasmin, transferrin, hapto­
globin, thyroxine-binding protein and corticosteroid transporting glyco­
protein (Seal and Doe, 1962). Chandrasekhar et al. (1962) studied the 
glycoprotein in the prothrombin and fibrinogen. They suggested that the 
sialic acid component of fibrinogen may have a role in regulating the 
19 
clotting mechanism. Kabat (1956) reported that the blood group substances 
are glycoproteins with antigenic properties. It has become apparent 
that the serologic specificity of the blood group substances resides in 
their carbohydrate portion which consists of approximately 75 percent of 
the molecule and the sugars present are fucose, galactose, glucosamine 
and galactosamine. The differences in amino acid composition do not ap­
pear to influence the immunologic specificity whereas alteration in carbo­
hydrate structure has a marked effect on antigenic properties. Clamp and 
Jones (1968) have shown that the oligosaccharide units of a soluble 
glycoprotein have antigenicity as assessed by inhibition of passive 
hemagglutination and passive cutaneous anaphylaxis reactions. The glyco­
proteins have been found in the mucous secretion of the salivary glands, 
the bronchi, the stomach, the cervix and the bile ducts. The viscous 
properties of this secretion have been attributed to the physical proper­
ties of the glycoproteins present. These glycoproteins from epithelial 
mucous secretions contain as their sugar constituents sialic acid, fucose, 
galactose, glucosamine and galactosamine. Gottschalk (1969) reported the 
high viscosity of the ovine submaxillary gland glycoprotein has been 
attributed to the presence of negative charges of the sialic acid residues 
in the disaccharide units distributed along the length of the peptide 
chain. With selective removal of the sialic acid residues with neuramini­
dase, there is a marked decrease in the viscosity. 
Serum glycoprotein 
The level of glycoproteins in serum is relatively constant in an 
individual under normal conditions, but is changed slightly by even minor 
ailments. Certain pathological conditions such as cancer, rheumatoid 
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arthritis, tuberculosis are characterized by elevated serum glycoprotein 
and seromucoid levels (Winzler, 1955; Shetlar, 1961). Weimer and 
Humelbough (1965) have found that food restriction and protein depletion 
in rats brought about a decrease in protein-bound hexose (PBH) and sero­
mucoid. Davis and Richmond (1968) reported that hexosamine and sialic 
acid components of glycoprotein in serum were reduced in induced protein 
deficiency in the rat. Patwardham et al. (1971) reported that the pro-
tein-bound hexose (PBH), a-glycoprotein and seromucoid were markedly 
elevated in the protein-calorie deficiency disease in children. Bogden 
et al. (1967) found that the a-2 glycoprotein level increased in adjuvant-
induced polyarthritis. Bogden and colleagues (1968) studied the relation 
between glycoprotein synthesis and concentration of steroids, and found 
that the synthesis of a specific glycoprotein is a quantitative reflec­
tion of trauma. They observed a linear increase in serum glycoprotein 
concentrations in traumatized adrenalectomized animals receiving increas­
ing dose levels of Cortisol. They suggested that glycoprotein synthesis 
can be used as a sensitive and specific assay for the study of anti­
inflammatory activity of both natural and synthetic 11-oxygenated cortico­
steroids as shown by the parallelism between dose-response curves ob­
tained and the relative potencies of these compounds as anti-inflammatory 
agents. Tobiska et al. (1969) also reported that the abscesL induced by 
injecting a sterile turpentine oil into germ-free rats elevated the con­
centration of glycoproteins and seromucoids. 
Patterson et al. (1963) found that the carcinosarcoma induced the 
elevation of the total serum-bound carbohydrate to increase by the third 
day prior to visible growth of the tumor. The serum-bound carbohydrate 
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remained elevated throughout the experiment. Snyder and Ashwell (1971) 
also reported the serum concentrations of glycoprotein and serumucoid were, 
significantly increased during malignancy in man. Murphy et al. (1972) 
showed a marked increase of glycoprotein in malaria and they proposed that 
the serum glycoprotein change was the result of an initial inflammatory 
response. Mousa et al. (1973) also reported the increased serum glycopro­
tein levels in acute and chronic malaria in man. Mouser et al. (1976) 
found that the glycoprotein electrophoretic pattern was significantly 
altered in schistosomiasis; a-1 and y-glycoprotein were significantly 
elevated above the normal concentrations. Dugan et al. (1968) found that 
the influence of estradiol on immature rat uteri caused a significant in­
crease in total protein and sialic acid. 
Glycoproteins of cell surface 
The presence of glycoprotein on the surface of mammalian cells is 
well-documented (Cook, 1968). Rombourg and Leblond (1967) used periodic 
acid-silver methenamine, a technique specific for glycoprotein detection. 
They found that nearly all cells were coated by a thin layer of stained 
material and this structure contained not only glycoproteins but also 
acidic residues. They pointed out that carbohydrates may play a role in 
holding cells together and in controlling the interactions between cells 
and environments. The carbohydrates possess unique immunological, ce­
menting, and other properties, which may vary from cell type to cell type. 
Glossmann and Neville (1971) studied the glycoprotein of cell surface 
membrane from the liver, kidney, and brush border of the rat and found 
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that there are four subunits which have molecular weights from 96,000 to 
250,000 all are prominent Schiff-positive glycoprotein containing sialic 
acid. 
A role of glycoprotein in specific cell adhesion is also suggested by 
Margoliash et al. (1965) who found a high uptake and concentration of 
glycoprotein on the cell surface. Oppenheimer et al. (1969) showed that 
the intercellular adhesion depended on the incorporation of sugar into 
macromolecules on the cell surface. They assumed that the process of cell 
recognition and cell adhesion required glycoproteins. Springer and Ansell 
(1958) investigated the effect of influenza viruses and receptor-destroy­
ing enzyme from Vibrio cholerae upon serologically recognized receptors of 
human erythrocytes. They found that influenza virus and receptor destroy­
ing enzyme are capable of inactivating or removing blood group agglutino­
gens M and N from human erythrocytes. Ambrose and Roe (1966) have sug­
gested that the increased sialic acid content of malignant cells, com­
pared to normal, may be responsible for the loss in affinity of these 
cells for each other and, therefore, for the metastasis of various cells. 
However, the plasma membrane glycoproteins have been implicated as par­
ticipating in the mutual recognition and adhesiveness of like cells to 
form aggregates of tissue. 
Rosen et al. (1958) first described the disease called pulmonary 
alveolar proteinosis which is characterized by excessive accumulation of 
periodic acid-Schiff (PAS)-positive amorphous material within the alveoli. 
Kuhn et al. (1966) observed the proliferation of the alveolar type II 
cells in lungs of patients with alveolar proteinosis and suggested that 
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the intra-alveolar material was derived from degenerated or desquamated 
alveoli cells. Lambson and Cohn (1968) studied the ultrastructure of the 
lung of the goose and its lining of surface material. They found that 
avian atria and respiratory bronchioles are lined by a multilaminated 
membrane surface. Osmiophilic inclusions are found in the type II epi­
thelial cells of the atria, but unlike mammalian lungs, no Clara, globlet 
or ciliated cells are present in avian airways. Bhattacharyya et al. 
(1975) isolated glycoproteins from lung lavage of rabbits and found the 
glycoprotein had molecular weight of 62,000 and 36,000. They pointed out 
that these two collagen-like glycopeptides are major intra-alveolar pro­
teins in many mammals including man. Bhattacharyya et al. (1976) studied 
the glycoprotein from lavage of normal chicken lungs and found it to have 
molecular weight of 36,000 daltons. They suggested that this glycoprotein 
may be a product of type II cells, since the chicken lung contained only 
alveolar type II cells. 
N-Acetyl Neuraminic Acid (Sialic Acid) 
The sialic acid occurs as a constituent of mucoproteins, mucolipids 
and lipoprotein-carbohydrate complexes in animal tissues, and is found in 
glandular secretion, excretions, blood serum and as a constituent of cell 
surface (Gottschalk, 1960). The sialic acids have received special atten­
tion as normal constituents of various glycoproteins. Among them, certain 
circulating sialoglycoproteins called "acute-phase reactant" proteins in­
crease in concentration in the serum in a number of pathologic states. 
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The pathologic changes can be detected by the increased level of sialic 
acids in sera of patients. 
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N-acetyl neuraminic acid 
There are many methods available for determining sialic acids in biologi­
cal materials. The direct histochemical method for the demonstration of 
sialic acid was developed by Shear and Pearse (1963). Svennerholm (1958) 
developed the resorcinol procedure for the determination of sialic acid in 
body fluids such as serum, lymph, milk, synovial fluids and transudates. 
Warren (1959) developed a very sensitive method for determination of 
sialic acid. This method involves the use of thiobarbituric acid as a 
reagent and is relatively specific for free sialic acids. Engen et al. 
(1974) adapted this method to the autoanalyzer for measuring sialic acid 
and 2-deoxy ribose in blood and tissue samples. Gottschalk (1960) ob­
served that human serum contains no free sialic acid and that 90% of the 
serum sialic acid is bound to the a and 3-globulin, and the only member of 
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the sialic family so far identified in human serum is the N-acetyl de­
rivative of neuraminic acid (NANA). Carter and Martin (1962) reported the 
increase of sialic acid level in rheumatoid arthritis, cirrhosis, myeloma 
and macroglobulinaemia. The increase in serum sialic acid levels is asso­
ciated with the presence of excess of 19S globulin. Since 90% of the 
sialic acid in normal sera is bound to the a and g-globulins it is 
reasonable to anticipate that under conditions in which these fractions of 
the serum protein pattern are increased, there may also be a raised level 
of sialic acid. Singh and Ramraju (1967) used Warren method to survey the 
sialic acid level in serum of healthy Indian adults and found the average 
value was 56 mg % with no difference by age or sex. Singh et al. (1967) 
reportd the significant increase of serum sialic acid in the malignancies 
but McClelland and Bridges (1973) found a lower sialic acid content in 
lymphocytes from patients with chronic lymphatic leukemia than in the 
normal lymphocytes. Serum sialic acid values also increase in cancer, 
leukemia, and pneumonia (Gottschalk, 1960). 
Fuller and Engen (1971) reported the sialic acid levels in normal 
beagles ranged from 55.8 to 59.3 mg %. Engen (1971) reported the serum 
sialic acid is significantly increased in the dogs infected with canine 
distemper. The serum sialic acid concentration in normal dogs was 50.9 
mg % as compared to 79.7 mg % in distemper infected dogs. 
Some biological activity of sialic acid 
Several factors indicated that analysis of the sialic acid composi­
tion represented an ideal way in which to begin a broad survey of the 
comparative biochemistry in some hormones. Sialic acid is relatively 
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easily removed from the protein by treatment with enzyme neuraminidase 
(Gottschalk, 1960). There are many workers who have shown that sialic 
acid is an important part of the carbohydrate moiety with respect to the 
biological activity of the molecule of mammalian gonadotropins. Licht 
and Papkoff (1972) found that by desialylation of gonadotropins with 
neuraminidase the loss of activity was between 70 and 90% and all mammal­
ian and avian gonadotropins were inactivated. The desialylation of ovine 
or human FSH by neuraminidase destroys most of the activity of the hormone 
in vivo as indicated by mammalian bioassay (Papkoff, 1965; Amir et al., 
1966). In contrast, luteinizing hormone (LH, ICSH) of ovine, bovine, and 
porcine origin lack sialic acid and are unaffected by neuraminidase 
(Adams-Mayne and Ward, 1964; Papkoff, 1966). Coppola and Ball (1966) 
reported the uterine sialic acid concentration in ovariectomized rats was 
directly proportional to the level of estrogen administered and inversely 
proportional to that of progesterone. Rajalakshmi et al. (1969) showed 
that estrogen induced a sharp increase in uterine sialic acid and the 
level of sialic acid 6 hours after clomiphene (estrogen antagonist) treat­
ment was significantly less than that caused by estrogen at the same time 
period. However, Kennedy and Emmens (1975) reported that progesterone was 
found to increase uterine sialic acid concentration above that induced by 
estradiol-!76 alone in ovariectomized rats. 
Sinha and Melnykovych (1972) found that sialic acid is released into 
the culture medium in the form of sialopeptides and that the accumulation 
of these sialopeptides in the medium is decreased when cells are grown in 
the presence of prednisolone. The synthesis of sialopeptidase was 
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depressed by prednisolone (Sinha and Melnykovych, 1973). They also 
pointed out that the surface glycopeptides are involved in the control of 
growth in cultures of epithelioid cells of neoplastic origin. Kraemer 
(1956) and Carubelli and Griffin (1967) found that the sialic acid content 
of Hela cells growing exponentially in monolayer cultures increased with 
the presence of hydrocortisone. Engen (1970) reported the serum sialic 
acid level is significantly increased in the dog treated with hydro­
cortisone and dexamethasone. 
Hirst (1941) was the first who found that a virus can adsorb to 
chicken red blood cells. The influenza virus and Vibrio cholerae possess 
enzyme neuraminidase. The action of neuraminidase renders the red blood 
cells unable to adsorb virus by removal of the specific receptors 
(Gottschalk and Lind, 1949). The product removed is sialic acid of which 
N-acetyl neuraminic acid is the principal form in virus-binding mucopro-
tein (Zilliken et al., 1957). Gottschalk (1956) showed that the sialic 
acid moiety of mucoprotein occupies a terminal position in an oligo­
saccharide. When mammalian cells are infected with certain viruses, 
especially myxo- or paramyxo-viruses, the virus particles are adsorbed to 
receptors such as the sialic acid residues (Haff and Stewart, 1965). 
Levenson et al. (1969) showed that the sialic acid was the active 
substituent on the horse serum inhibitor of influenza virus, and profound 
changes in the inhibition of the virus occurred when a chemical agent 
such as sodium metapsriodate was used, which makes relatively minor 
alterations of the sialic acid. Gottschalk (1966) discussed the criteria 
that glycoproteins must fulfill to be effective inhibitors of influenza 
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virus hemagglutination, and he concluded that the effectiveness of an 
inhibitory substance is a function of molecular size, the number of 
terminal sialic acids and the three-dimensional structure complementary 
to an area on the virus surface. 
Van Herick and Eaton (1945) reported the hemagglutination of turkey 
and blood cells by Mycoplasma gallisepticum. Gesner and Thomas (1965) 
demonstrated that the hemagglutination of turkey erythrocytes by Myco­
plasma gallisepticum was inhibited by mucoproteins containing sialic 
acid, or by sialic acid itself, or by treatment of the erythrocytes with 
neuraminidase. They suggested that sialic acid on the erythrocyte surface 
provides binding sites for Mycoplasma gallisepticum. Mycoplasma pneu­
moniae is the most virulent of the mycoplasmas for humans (Chanock, 1965). 
It has been suggested that its virulence is due, in part, to a peroxide 
hemolysin secreted by this organism which diffuses to the cell membrane 
and thus enhances injury of affected cells (Cohen and Somerson, 1967). 
Sobeslavsky et al. (1968) showed clearly that monkey, rat, and chicken 
tracheal epithelial cells, as well as monkey, rat, guinea pig and chicken 
erythrocytes adsorbed firmly to colonies of Mycoplasma pneumoniae and 
Mycoplasma gallisepticum. Mycoplasmas appeared to bind to neuraminic acid 
receptors on erythrocytes or tracheal epithelial cells as pretreatment of 
red cells or tracheal epithelial cells with either receptor-destroying en­
zyme neuraminidase or influenza B-virus, removed the adsorption receptor 
for M. pneumoniae. Pretreatment of M. pneumoniae colonies with neuraminic 
acid containing materials prevented adsorption of erythrocytes or respira­
tory tract cells. Sobeslavsky and collaborators pointed out that the 
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affinity of M. pneumoniae for respiratory tract epithelium may play a role 
in virulence since this type of attachment provides an unusual opportunity 
for peroxide, secreted by M. pneumoniae to attack the tissue cell membrane 
without being rapidly destroyed by catalase or peroxidase present in 
extracellular body fluids. 
Pulmonary Function Tests 
Wilson et al. (1976) suggested that the methods for measuring of the 
pulmonary functions can be divided into the following categories: 1) 
ventilatory exchange, a measurement of volumes of gases exchanged during 
breathing; 2) static lung volumes, providing useful information about the 
strength and elasticity of the respiratory system; 3) respiratory mechan­
ics; 4) distribution of ventilation; 5) pulmonary circulation including 
the measurement of vascular pressures; 6) regional ventilation/perfusion 
matching (V/Q); 7) diffusion capacity which is affected by a variety of 
lung diseases; and 8) blood gas measurement. Few respiratory parameters 
can be measured in animals because of their lack of cooperation. 
MacFarland (1976) suggested the subjects to be measured in animals as the 
following: 1) pulmonary mechanics, including respiratory rate, tidal 
volume, minute volume, airway resistance, and pulmonary compliance; 2) 
distribution of ventilation; 3) diffusion capacity; and 4) blood gases and 
pH. 
The review on pulmonary function tests is subdivided into five com­
ponents: 1) lung volume; 2) ventilation; 3) pulmonary mechanics; 4) 
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distribution of ventilation; and 5) pulmonary circulation and blood gas 
analyses. 
Lung Volume 
For the past century the total lung capacity (TLC) and its subunits 
have been measured by a spirometer. The spirometer has also been used for 
the routine measurement of basal metabolic rate (BMR). Bates et al. 
(1971) noted that in order to measure absolute gas volume in the lung, one 
of three different methods must be employed: inert gas dilution or wash­
out, whole body plethysmography, or radiological techniques. 
Tidal volume 
Tidal volume (Vj) is the volume of gas inspired or expired during a 
single respiratory cycle. Comroe et al. (1962) suggested that tidal 
volume is not useful as an index of alveolar ventilation because either 
increased or decreased tidal volume may be associated with hyper- or 
hypoventilation, depending on other factors. However, when tidal volume 
is considered along with frequency, it is possible to diagnose hypoventi­
lation without the necessity of other tests. Tidal volume is primarily of 
importance because it is one of the determinants of "minute volume," the 
volume of gas pumped into and out of the upper airways per minute (tidal 
volume x respiratory frequency = minute volume). 
Alveolar Ventilation 
The alveolar ventilation can be calculated by subtracting the dead 
space ventilation from the minute ventilation. 
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Alveolar ventilation = Respiratory frequency x (tidal volume - dead 
space volume) 
In man, when 9/Q ratios are similar throughout the lungs, as in 
normal subjects, an alveolar ventilation at rest of about 4 liters per 
minute is adequate. When the V/Q ratios are unbalanced throughout the 
lung or when the lung is destroyed by disease, the alveolar ventilation 
will be greater in order to maintain normal arterial gas tensions. The 
only satisfactory method for the measurement of effective alveolar venti­
lation is by the measurement of arterial CO2 tension (Bates et al., 1971). 
Forster (1974) suggested that the minute volume which included the dead 
space and the effective alveolar ventilation should not be considered as 
an effective indicator of ventilation efficiency for respiratory gas ex­
change, because there is no significant gas exchange with blood occurring 
at "anatomical respiratory dead space" which includes pharynx, larynx, 
trachea, bronchi and bronchioles. Respiratory dead space or physiological 
dead space (Vp) is the value of lung which has no gas exchange and is made 
up of two compartments: anatomic dead space and alveolar dead space which 
is the nonfunctioning alveoli. Vp can be determined by the Bohr's equa­
tion as described by Ruppel (1975) or a single breath analysis method as 
described by Buist (1975). However, the size of anatomic dead space 
varied with the size and posture of the individual (West, 1974). In 
mammals the size of the anatomical dead space of a normal individual in 
milliliters is approximately numerically equal to its weight in pounds 
(Forster, 1974; Ganong, 1975). 
A decrease in alveolar ventilation causes CO2 retention. A lower 
ventilation occurs in several diseases such as muscular weakness. 
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poliomyelitis, central depression from pharmacologic agents as in general 
anesthesia or intoxication or Increase In physiologic dead space in 
emphysema (Forster, 1974). The magnitude of arterial PCO2 depends on 
pulmonary function, including the frequency of respiration. Thus, an in­
creased arterial PCO2 indicates a decrease In alveolar ventilation (hypo­
ventilation) and decreased arterial PCO2 indicates an increase in alveolar 
ventilation (hyperventilation). With modern equipment for blood gas 
analysis the combination of blood gas analysis and the measurements of 
ventilation become the best methods in clinical practice for evaluation of 
pulmonary function in man and animals as reported by Pickrell et al. 
(1971), Forster (1974), and Gillespie and Hyatt (1974). 
Lung Mechanics 
Lung mechanics involves the action of the lungs and thorax in pumping 
gas into and out of the alveoli. In general, the lung mechanics can be 
subdivided Into four components: 1) dynamic lung compliance, 2) airway 
resistance, 3) collapse of the airways, and 4) work of breathing. 
Lung compliance 
Measurements of lung compliance provide only limited information as 
to the absolute elastic properties of lungs. Compliance is Influenced by 
lung volume and respiratory frequency. Forster (1974) suggested that com­
pliance is a very useful concept clinically because it gives a measure of 
the changes in lung elasticity with disease. A decrease in compliance of 
the lung means that the lung has become stiffer, as in fibrosis, pulmonary 
edema, or pleural thickening. Compliance can become greater when the lung 
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becomes more distensible, as it does in emphysema, presumably from loss of 
elastic tissue. The only adequate measure of the lung elastic properties 
is the dynamic pressure-volume curve of the lung, in which absolute trans-
pulmonary pressure is related to absolute lung volume over the whole vital 
capacity range, on both inflation and deflation. If volume is measured 
plethysmographically or by integration of the pneumotachograph signal and 
the transpulmonary pressure measured by insertion of esophageal balloon, 
dynamic compliance can be determined (Fry et al., 1952). Changes in 
intra-esophageal pressure are equal to changes in intrapleural pressure 
(Milic-Emili et al., 1964; Dubin, 1970; Gillespie and Hyatt, 1974). The 
dynamic lung compliance equals the slope of a graph of lung volume vs. 
intrapleural pressure. In patients with emphysema the curve is shifted 
upward and to the left indicating a marked loss of elastic recoil. In 
asthmatic subjects with bronchospasm there is also loss of recoil (Gold 
et al., 1967; Woolcock and Mead, 1968). In patients with pulmonary 
fibrosis the curve is shifted downward and to the right, indicating a 
marked increase in elastic recoil at all lung volumes. There are many 
factors contributing to the shape and position of the static pressure 
volume curve of the lung (Figure 1). There is a surface tension at the 
tissue-gas boundary which tends to collapse the alveoli, and which in­
creases the force required to expand the lung (decrease the compliance). 
Pulmonary surfactant, dipalmitoyl lecithin complexed with protein, has 
been extracted from saline lavage of normal lung and is essential to the 
stability of the lung and thereby effective ventilation and gas exchange 
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(Dubin et al., 1971). In premature infants the pulmonary surfactant is 
decreased as compared to full term infants (Gluck et al., 1971). 
Airway resistance 
Airway resistance is the most exact measurement of airway obstruc­
tion. The calculation of airway resistance requires simultaneous measure­
ment of air flow and alveolar pressure as estimated by esophageal pres­
sure. Airway resistance and tissue resistance contribute to total 
pulmonary resistance, but airway resistance contributes most of the total 
resistance (Forster, 1974). Airway resistance has been shown to be de­
pendent upon two factors: 
1. Lung volume: The airway resistance varies inversely with lung 
volume. The change with lung volume is due to the increase in 
diameter of the airways as the lung volume increases. The 
elastic elements in the lung are attached not only to the pleural 
surface but also to the outer walls of airways and extra-alveolar 
blood vessels with the result that peribronchial pressure is 
equal to or more negative than pleural pressure (Hyatt and Flath, 
1966). In dogs, the greatest changes in resistance with lung 
volume occur in 3 to 8 mm diameter airways (Macklem et al., 
1969). 
2. Relative resistance of central and peripheral airways: The con­
tribution of different sized airways to the total pulmonary re­
sistance has been measured in dogs (Macklem and Mead, 1967) and 
in man (Hogg et al., 1968). 
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According to the Poiseuille relationship for viscous flow, airway 
resistance should decrease as the fourth power of the effective radius of 
the airways (Comroe, 1974). The resistance of the upper airway is about 
50 percent and that of the peripheral airways about 5 to 15 percent of 
total pulmonary resistance (Hyatt and Wilcox, 1961; Ferris et al., 1964). 
Hogg et al. (1972) demonstrated little increase in total airway resistance 
in chronic obstructive airway disease patients but a fourfold increase in 
peripheral resistance. 
Collapse of the airways 
McCarthy et al. (1972) and Forster (1974) reported that even in 
healthy individuals, some bronchioles close when lung volume is reduced 
during expiration to 5 to 10 percent of vital capacity. This is called 
"closing volume." Holland et al. (1968) reported the airway closure 
occurred at the level of the resting Functional Residual Capacity (FRC) 
in man ages 66 and 75. Anthonisen et al. (1969) reported that the closing 
volume at age 20 is at a lung volume less than 10 percent of the vital 
capacity, but at age 40 closing occurs at about 20 percent of vital 
capacity. 
The work of breathing 
Fenn (1951) first drew attention to the various factors involved in 
the work of breathing. Subsequently the work of breathing has been ex­
tensively reviewed by Otis (1954). Energy is required to pump the minute 
ventilation into and out of the lungs. The work is done by the diaphragm 
and intercostal and accessory muscles of respiration. Normally these 
muscles do most or all of their work during inspiration, overcoming the 
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elastic force of the lung and thoracic cage as well as the viscous re­
sistance of gas flow through the bronchial tree. During expiration the 
elastic recoil of the lung and thoracic cage exerts a force tending to 
return the lungs to resting and expiratory level (PRC), so that no 
muscular effort is normally needed. During a forced expiration or in 
disease in which expiratory resistance is increased, muscular effort is 
required. In general the work of breathing is about 5 percent of the 
resting metabolic rate (Forster, 1974). 
During steady-state breathing conditions it is possible to compute 
the work of breathing in mechanical terms as the relationship of pressure 
(which is an expression of force) to volume (which is an expression of 
distance). Since pressure x volume (g/sq cm x cucm = g x cm) has the same 
dimensions as work (force x distance), it is most convenient to measure 
work of breathing as pressure x volume (Ganong, 1975). Mammals of very 
different size naturally breathe at rates and depths that represent their 
own minimal rates of respiratory work as demonstrated by Crosfill and 
Widdicombe (1961). Widdicombe and Nadel (1963) explored the interrela­
tionship that exists between anatomical dead-space volume and work of 
breathing at given levels of alveolar ventilation and suggested that 
alterations in airway caliber might represent adjustments to ensure 
maintenance of a minimal work of breathing. 
Distribution of Ventilation 
A common cause of hypoxemia in the diseased lung is the unequal 
distribution of ventilation to perfusion. Such inequalities primarily 
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arise from unequal distribution of ventilation to various lung regions. 
There are a number of possible causes of unequal gas distribution in the 
lung: 1) regional ventilation distribution; 2) relation between airway 
resistance and ventilation distribution; 3) airway closure; and 4) 
gaseous diffusion (Bates et al., 1971). 
Regional ventilation distribution 
Milic-Emili et al. (1966) studied the regional distribution of in­
spired gas in the lung in man by using ^^'Xenon and found that regional 
volumes were always greater in upper than in lower lung zones. They 
pointed out that the uneven distribution of ventilation in the normal lung 
is the consequence of regional differences in pleural pressure. Zardini 
and West (1966) studied the topographical distribution of ventilation in 
isolated dog lungs. When the lung was inflated in small steps, most of 
the i^^Xenon initially went to the upper zone, but at larger lung volumes 
the lower zone was preferentially filled. They concluded that the uneven 
distribution of ventilation in the human lung is not caused by the uneven 
distribution of blood flow but by the vertical gradient of the intra­
pleural pressure. The intrapleural pressures at different sites in the 
thorax and the effects of different body positions on these pressures play 
a role in pulmonary mechanics (Mead, 1961), and fluid dynamics (Agostoni 
et al., 1957). Hydrostatic effects are of considerable importance in 
cardiopulmonary circulation and may also affect intrapleural pressures. 
Kaneko et al. (1966) reported that in all body position studies, the 
regional RV, PRC, and ERV were greater in upper part of the lung that in 
dependent lung regions. They pointed out that in normal men both 
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ventilation and perfusion are relatively greater in the direction of 
gravity. Bryan et al. (1966) studied the regional variations in lung 
volume and in distribution of ventilation by measuring i**Xenon incorpora­
tion during normal gravity and during increased positive acceleration on a 
human centrifuge. They concluded that the probable cause of the regional 
differences in volume and ventilation which have been demonstrated is a 
gradient of static transpulmonary pressure down the lung. This gradient 
appears to be related to the weight of the lung. Bates et al. (1971) 
summarized that there is little doubt that regional ventilation distribu­
tion plays a major part in determining patterns of nonuniformity in lung 
ventilation under a wide variety of circumstances. The balance between 
ventilation and perfusion is achieved under resting conditions. Age, 
obesity, body position, acceleration, and weightlessness affect gas 
exchange. 
Relationship between airway resistance and ventilation distribution 
One of the most remarkable features of young normal lungs is that the 
millions of alveoli fill and empty synchronously during both slow and 
rapid breathing. Hogg et al. (1969) showed that in emphysema the re­
sistance of collateral channels is very low, lower than airway resistance. 
In some patients with emphysema collateral channels are extremely impor­
tant ventilatory pathways. Woolcock and Macklem (1971) reported that the 
collateral ventilation is rapid in the dog and man but is slow or absent 
in the pig. Macklem et al, (1969) concluded that the synchronous behavior 
is achieved in lungs in spite of time-constant inequalities of moderate 
degree because: 1) the resistance of peripheral airways is low; 2) 
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because of interdependence of lung units; 3) because in some species, 
ventilation of airspaces through collateral channels may occur just as 
rapidly as ventilation of these spaces through airways. 
Airway closure 
If breathing takes place at low lung volume, i.e., near residual 
volume, the upper lung units are better ventilated than those in the 
dependent zones. This reversal of ventilation distribution has been 
attributed to airway closure (trapping) in the dependent lung zone (Milic-
Emili et al., 1966). The airway closure occurs when the pleural pressure 
must be greater than airway pressure (Dollfuss et al., 1967). As lung 
volume approaches residual volume (RV), the pleural pressure in the lower 
lung zones indeed exceeds airway pressure, causing trapping in the de­
pendent lung zones. If then a small breath is inspired, the trapped units 
in the lower lung regions do not receive any of the inspired air. Conse­
quently, the inspired air is delivered predominantly to the upper lung 
during slow and shallow breathing. Macklem and Mead (1967) found that the 
resistance of peripheral airways, i.e., airways smaller than 2 mm diam­
eter, is only a small part of the regions. In normal young subjects air­
way closure in the dependent lung zone is present only at lung volume 
below the functional residual capacity (Milic-Emili et al., 1966). With 
increased age, however, the lung volume at which the airways close would 
be expected to increase because the lungs of elderly subjects lose elastic 
recoil (Turner et al., 1968), Hence, pleural pressure in the lower lung 
zones will exceed airway pressure at lung volumes higher in elderly sub­
jects than in young subjects. 
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Gaseous diffusion 
The actual exchange of gases in the lungs takes place by diffusion 
between the alveolar gas and capillary blood. Although the importance of 
the process of gas diffusion between the alveoli and pulmonary capillary 
blood has been known for 50 years, the aspect of pulmonary function test 
has been clarified only since 1945 (Bates et al., 1971). Carbon monoxide 
(CO) has approximately 250 times as great an affinity for hemoglobin as 
does oxygen. An alternative gas for measuring diffusion is 0%, but be­
cause the capillary PO2 rises during transit to approach equilibrium with 
alveolar gas, the estimation of mean capillary PO2 is extremely difficult 
and inaccurate (Forster, 1974). 
Carbon monoxide has been used extensively in the study of pulmonary 
diffusion because it 1) diffuses passively across the alveolo-capillary 
membrane, 2) combines tenaciously with hemoglobin, and 3) exerts an ex­
tremely low partial pressure in pulmonary capillary blood so that the 
alveolar carbon monoxide tension may be considered to be almost equal to 
the alveolar-arterial carbon monoxide gradient. A number of carbon 
monoxide techniques have been proposed (Forster, 1957). 
The basic diffusion equation for CO 
OL -
PSco-PCco 
where 
DLgg is the diffusing capacity of the lung for CO, the unit was ml/ 
min/mmHg. 
Pa__ is alveolar CO tension. 
CO 
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PCco is capillary CO tension, this value is usually extremely low and 
may be disregarded. 
Vco is carbon monoxide uptake. 
There are many factors affecting diffusion in a single alveolus: 1) 
thickness of alveolar lining membrane; 2) thickness of alveolar lining 
cell; 3) permeability of capillary wall; 4) thickness of layer of plasma 
membrane between capillary wall and red blood cell; 5) permeability of 
red cell membrane to CO or 0%; 6) reaction rate of hemoglobin with CO and 
0%; 7) presence of COHb in the pulmonary artery blood, which will diminish 
rate of CO transfer. Ogilvie et al. (1957) suggested that the pulmonary 
diffusion capacity can be used to detect the obstructive disorders of the 
pulmonary circulation by using a rapid, single-breath screening test of 
pulmonary diffusing capacity. For the test the patient inhales a low, 
nontoxic concentration of carbon monoxide, holds the breath for 10 
seconds, and then exhales. The single-breath method can be used for 
measuring gaseous diffusion capacity in normal subjects and in heart dis­
ease (Bedell and Adams, 1962), acute pulmonary tuberculosis (Williams 
et al., 1961), anemia (Rankin et al., 1961), asbestosis (Williams and 
Hugh-Jones, 1960), and emphysema (Apthorp and Marshall, 1961). 
Pulmonary Circulation/Blood Gas Analysis 
The hemodynamics of the pulmonary circulation are complicated because 
the vascular resistance is influenced by three extravascular pressures: 
1) atmospheric pressure, since if the blood pressure within the capillar­
ies becomes less than alveolar pressure the vessels will collapse; 2) 
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intrapleural pressure, because as intrapleural pressure falls in relation 
to ambient pressure with inspiration, pressure in the right and left sides 
of the heart also falls; and 3) pressure in the abdominal cavity, which 
surrounds the inferior vena cava and when it increases an increased pres­
sure gradient is produced from abdomen to thorax and venous return rises 
(Forster, 1974). 
Rahn and Farhi (1964) recognized the matching of ventilation and per­
fusion in the lung, and established the ventilation-perfusion ratio (^). 
If the ventilation and blood flow are mismatched in various regions of the 
lung, impairment of both 0% and COz transfer results. Forster (1974) 
observed that in the normal healthy lung capillary blood flow tends to be 
lower in the apices and greater in the bases. On the other hand, minute 
ventilation tends to be higher in the apices and lower in the bases. One 
important cause of this is that the weight of the lung makes inflation of 
an alveolus in the basal region more difficult. The net result is a high 
alveolar ventilation/capillary blood flow in the apices, with a corre­
sponding decrease in PCOz and rise in POz, and the reverse result is ob­
tained for the bases. The local mechanism for control of airway resist­
ance and capillary blood flow operate to reduce the nonuniformity. In 
many lung diseases this delicate adjustment is deranged, such as by de­
struction of some capillaries or local increases in airway resistance. 
This results in an increased arterial PCO2 and a decreased arterial POg. 
The most helpful, in many patients, estimate of alveolar ventilation is 
the measurement of the arterial PCO2. A decreased inspired PO2 leads to a 
decreased arterial PO2, which in turn causes hyperventilation because of 
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stimulation of the chemoreceptors (carotid or aortic bodies). This lowers 
arterial PCO2 secondarily. A decreased alveolar ventilation, whether from 
decreased minute ventilation or increased dead space volume, will lead to 
an increased arterial PCO2 and a decreased arterial PO2. A reduced 
pulmonary diffusing capacity will tend to decrease arterial PO2, but will 
leave arterial PCO2 normal. Uneven alveolar ventilation/capillary blood 
flow will reduce arterial PO2 but leave arterial PCO2 normal. As the 
disease progresses, the unevehness of distribution will become more severe 
and the arterial PO2 will drop further and eventually the arterial PCO2 
will rise. Forster (1974) suggested that the situation in an actual 
patient is often a combination of metabolic and respiratory disturbance. 
It is necessary to know the values of the three variables in the 
Henderson-Hasselbalch equation in order to be able to determine a 
patient's acid-base status, that is arterial plasma HCO3-concentration, 
pH and PCO2. 
Ruppel (1975) noted that because CO2 diffuses twenty times as readily 
across the alveolar-capillary membrane as does O2, small changes in 
ventilatory pattern of distribution of gas will show little change in 
PaCOz. Since diffusion defects rarely raise PaC02, high CO2 tension 
strongly suggests that advanced pulmonary disease is present. The meas­
urement of pH and blood gas tension is useful for diagnostic procedure in 
animals as recommended by Feigl and D'Alecy (1972) and Pickrell et al. 
(1973, 1974). Loew and Thews found an average PaO, of 95 nmHg in adults 
between the ages of 18 and 30, falling to an average of 85 mmHg by age 35, 
and to an average of 75 mmHg at age 60 (Bates et al., 1971). These data 
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showed that the PaOz decrease occurs almost linearly with advancing age. 
However, the arterial PCO2 is not affected by age. 
Factors Influencing Pulmonary Function 
The ventilation, distribution, diffusion and perfusion components are 
essential to accomplish the gas exchange and gas transportation. There 
are many factors contributing to the alteration of these components of 
lung function. 
Age 
In human, there have been many studies on the effect of age on 
pulmonary parameters. There are many reports in humans that the residual 
and functional residual capacity increased with increased age, but the 
total lung capacity showed little change (Comroe et al., 1962). Mitten 
et al. (1965) reported that the chest wall compliance in man decreased 
significantly with age. Turner et al. (1968) reported that in human the 
static recoil pressures reducad throughout the age range of 20 to 60 
years. They also found that an increase in functional residual capacity/ 
total lung capacity (FRC/TLC) ratio increased with age. The loss of lung 
elastic recoil in the elderly is due to the decrease of chest wall com­
pliance. Leblanc et al. (1970) found that the closure volume increased 
linearly with age, and in seated subjects older than 65 years and in supine 
individuals older than 44 years there is significant impairment of 
ventilation distribution to the dependent lung zones, which necessarily 
causes impaired gas exchange within the lungs. Gelb and Zomel (1975) 
studied the influence of aging on lung mechanics in healthy nonsmokers and 
found an increased airway collapsibility during maximum flow with in­
creased age. The airway resistance in man increased in the old age 
(Ganong, 1975). It has been known for some years that elastic content of 
the human lung is increased in older subjects which would tend to make the 
structure more rigid (Pierce and Hocott, 1960a,b). There are important 
changes in the thoracic wall with age, particularly progressive calcifica­
tion of the chondral cartilage (Pierce and Ebert, 1958). Pierce and Ebert 
(1959) noted that the entire pressure-volume curve is shifted to the left 
with age. It is clear that there are three effects of age: 1) loss of 
elastic recoil, so that lung volume is greater at the same pressure dif­
ferential in the older lung; 2) shift of the curve over most of its 
course; and 3) increase in the volume of air in the lung at zero trans-
pulmonary pressure (Turner et al., 1968). Anthonisen et al. (1969) noted 
that the distribution of ventilation in the older subject is bound to be 
"unstable" and very much dependent on the actual tidal volume taken and 
the increased residual volume of age is due to premature closure of air­
ways due to loss of recoil. The ventilation distribution becomes de­
pendent on the magnitude of the tidal volume as the lung looses recoil with 
advancing age. 
There are many reports on the effect of age on the respiratory 
parameters in animals. Davidson et al. (1966) studied the effect of aging 
on respiratory mechanics and gas exchange in rabbits, and found the 
significant increase of functional residual capacity with age. The static 
compliance and elastic resistance increased in the old rabbit, signifying 
loss of elastic recoil and increased airway resistance. The changes are 
mild producing no disturbance of gas exchange. Mauderly (1968) reported a 
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significant increase in lung compliance with the older dogs. He observed 
that young dogs have higher ventilation and larger resting lung volume, 
and consume more O2 per kilogram body weight than do older dogs. A change 
of blood gas partial pressure can be observed in old dogs. The young dogs 
had lower arterial pH and increased arterial CO2 tension with no signifi­
cant change in 0% tension. Robinson and Gillespie (1972) found the older 
dog showed a decreased lung compliance and the changes in volume ratios in 
older dogs are similar to those seen in aging people. Robinson and 
Gillespie (1973) studied the mechanical properties of the lungs of aging 
dogs and found that with increasing age, there is an increase in the ratio 
residual volume/total lung capacity (RV/TLC) and plethysmographic func­
tional residual capacity/total lung capacity (FRC/TLC). They suggested 
that the increase of FRC/TLC appeared due to both a loss of lung elastic 
recoil in dogs over 1500 days of age and an increase in the resting volume 
of the thoracic cage. Knutsen (1976) reported that there are significant 
decreases of lung compliance, and significant increases of airway resist­
ance, work of breathing, and esophageal pressure in the older dog as 
measured during the sedative period. 
Weight 
In humans, the expected values for respiratory parameters as calcu­
lated on the basis of height and age of patient has been established 
(Comroe, 1974; Ruppel, 1975). Crosfill and Widdicombe (1961) studied the 
physical characteristics of the chest and lung, and the work of breathing 
in different mammalian species and found the lung resistance tended to 
increase with the size of the animal of each species. Stahl (1967) 
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studied the correlation between the body weight and lung volumes, lung 
compliance, and air flow in different sizes and species of mammals and 
found a correlation coefficient of between 0.99 to 0.90. Both Mauderly 
(1968) and Dubin (1970) also reported a significant increase of lung com­
pliance with the heavier dogs. Knutsen (1976) reported the significant 
increase of tidal volume, minute volume, inspiratory and expiratory 
velocity and esophageal pressure with the increase of body weight in 
sedated dogs. 
Sex 
In humans, Comroe et al. (1962) and Forster (1974) pointed out the 
difference of respiratory parameter between male and female. Hamlin and 
Smith (1967) studied the respiratory parameters in healthy dogs anesthe­
tized with sodium pentobarbital and found a significantly greater minute 
volume in male dogs, and the significantly larger tidal volume per kg 
body weight in female dogs. The weight of male and female dogs was simi­
lar, but the female dogs were significantly younger. Knutsen (1976) re­
ported that there is no influence of sex on the respiratory parameters in 
the sedated dogs. 
The pulmonary function tests are clinically used for screening 
respiratory diseases in small animals. However, there still are limita­
tions, because of lack of cooperation from animals. Robinson and 
Gillespie (1970) suggested that is is convenient to divide respiratory 
diseases into three functional types. 
1. Restrictive disease, the characteristics of restrictive disease 
being a reduced compliance and PRC. The disease can be due to 
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diffuse fibrosis within the lung, focal areas of consolidation or 
atelectasis or lesions occupying space within the chest. The re­
duction of compliance increases the work of breathing. The ani­
mals with restrictive disease minimize the work to maintain 
minute ventilation by rapid shallow respiration. 
2. Obstructive disease, the characteristic of which is increased 
PRC, with or without increased compliance, and expiratory 
dyspnea. Normally expiratory phase is passive and depends on the 
elastic recoil of the lung. The increase of compliance is usual­
ly associated with atrophic alveolar emphysema. 
3. Diffusion abnormality, which is the impairment of diffusion 
capacity due to a thickening of the alveolo-capillary membrane 
or a reduction in the number of functional pulmonary capillaries. 
There is a limitation for the measurement of the pulmonary function 
in the swine in the present experiments. Only some of the respiratory 
parameters such as tidal volume, esophageal pressure, respiratory flow 
rate, 0% consumption rate, and blood gas analysis can be measured under 
the anesthetic condition. 
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MATERIALS AND METHODS 
Experimental Animals 
All pigs were of mixed breeding. They were obtained from the 
respiratory disease-free herd maintained at the Veterinary Medical Re­
search Institute, Iowa State University. The original stock was estab­
lished from surgically derived pigs and the herd has been maintained in 
quarantine for at least 20 years. The pigs were housed in isolation units 
during the experiment. All the pigs were either Yorkshires or Hampshires 
and were 5 1/2 to 6 weeks of age at the beginning of the experiments. The 
pigs were fed a complete 16% protein grower ration free of antibiotics. 
Water was provided ad libitum by automatic waterers. 
Experimental Inoculations of Pigs 
In all trials pigs were held in isolation units for at least 3 days 
prior to inoculation to allow them to become accustomed to feed and sur­
roundings. Each pig was given two ml of a 10% suspension of homogenized 
pneumonic lung in Eagle's medium. The inoculum was administered by intra­
tracheal instillation with the head of the pig held in an up-right posi­
tion as the culture fluid was dripped into the trachea. To make sure that 
the needle was inserted intratracheal!y air was drawn back from trachea. 
The pigs were kept under observation for a varying number of weeks as de­
termined by the particular experiment. The pigs were observed for gen­
eral appearance, breathing pattern, presence of coughing and eating 
behavior. 
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Protocol for Experiment 1 
The pigs were divided into three groups, to be examined at the 
fourth, fifth or sixth week after intratracheal inoculation. The body 
weights were recorded at the beginning and the end of the period. 
Pulmonary Parameters Measurements 
At the end of each period, the pigs were anesthetized by intravenous 
1 injection of sodium pentobarbital (30 mg/kg body weight). Atropine 
sulfate (0.11 mg/kg) was administered intravenously. The animals were 
placed immediately into the prone position, and the laryngeal area was 
sprayed with a local anesthetic Cetacaine^ to prevent the irritation when 
inserting the endotracheal tube. The animals were then intubated with an 
appropriate endotracheal tube (8 mm-10 mm diameter). 
The polygraph multichannel (Beckman type R Dynograph) was used to 
record the EKG lead II (channel 1), values for esophageal pressure (chan­
nel 2), respiratory rate, inspiratory and expiratory velocities (channel 
3), tidal volume (channel 4). 
The intrapleural pressure changes were estimated with an esophageal 
balloon catheter. The balloon, 4.0 cm long and 1.0 cm in diameter con­
taining 3 ml of water, was attached to the end of a polyethylene catheter. 
The catheter was connected to a Statham P23Db pressure transducer and 
^Med-techj Inc., Elwood, Kansas. 
2 Burns-Biotic Laboratory, Oakland, California. 
^Cetylite Industries, Inc., Long Island City, New York. 
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pressure changes were recorded on the dynograph. The balloon was lubri­
cated and inserted into the esophagus to approximately the lower middle 
third of esophagus. If the balloon was placed too caudally, the heart 
beat would show on the recording. Attempts were made to place the balloon 
in the same relative position in each pig in order to get the best ex­
pression of esophageal pressure. The measurement of airflow (inspiratory 
and expiratory velocity) was achieved by using a Fleisch #0 pneumotacho­
graph having a linear response to 27 L/min. A Statham PM5 differential 
pressure transducer was connected to the pneumotachograph and recordings 
were made on channel 3 of the Beckman type R dynograph. 
The tidal volume was determined simultaneously by electronic integra­
tion of the flow signal, and was recorded on channel 4. 
The Hewlett-Packard 7035B X-Y recorder simultaneously measured the 
pressure-volume loop, in order to calculate the dynamic lung compliance, 
pressure-flow loop, for calculation of airway resistance, flow-volume 
loop, and to determine the inspiratory and expiratory velocity. 
The values of tidal volume and respiratory rate were obtained direct­
ly from the recordings and lung compliance was determined as the ratio of 
tidal volume to the difference in intraesophageal pressure at points of 
zero flow during inspiration and expiration. The airway resistance was 
computed by dividing intraesophageal pressure by the maximum expiratory 
flow at end inspiration and end expiration at the instants of no airflow 
during breathing. 
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The Measurement of 0% Consumption 
The oxygen consumption was measured immediately after the measurement 
of respiratory parameters. The endotracheal tube was connected to a 9 
liter spirometer^ filled with oxygen. After a 5 minute equilibration 
period, oxygen consumption was recorded for 5-6 minutes. 
Hematologic Procedure 
Blood sample collection 
The groin area was shaved and swabbed with 70% alcohol, the femoral 
artery and vein were surgically exposed and the long dwell needles were 
inserted. The skin was partly sutured closed to hold the long dwell 
catheter. A heparinized 2 ml glass syringe was attached. The arterial 
and venous blood samples were collected during the pulmonary function 
measurement. The syringes were sealed with the metal cap to exclude air 
bubbles and placed in an ice bath pending blood gas tension analysis. 
At the end of the respiratory parameters measurement, a 50 ml plastic 
syringe with the dead space filled with heparin solution was used to 
collect about 35 ml of blood. The blood was centrifuged at 3000 rpm for 
10 minutes and plasma removed. The plasma was stored in the freezer at 
-30°C for further analysis. 
^Godard N.V., Bilthoven, Holland. 
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Blood cell counts 
Erythrocyte (RBC) and leukocyte (WBC) counts were determined. Dif­
ferential leukocyte counts were made on smears stained with Wright's blood 
stain, and absolute numbers were calculated. 
Packed cell volume 
Packed cell volume (PCV) was determined by the micro-hematocrit 
method using capillary tubes. The tubes were sealed with critoseal and 
centrifuged at 15,000 rpm for 3 minutes. The percent of packed red blood 
cells was determined. 
Hemoglobin 
The hemoglobin (Hb) concentration was determined by the cyanometho-
emoglobin method.^ 
Plasma protein studies 
The total plasma protein was determined with a direct reading re-
2 fractometer. 
Plasma protein and glycoprotein electrophoresis 
Plasma protein electrophoresis was performed with a Model 1400 
O 
electrophoresis system according to the method described by Davis (1964). 
A 7 percent aery 1 amide gel and a tris-glycine buffer with a pH of 9.5 was 
used. The electrophoresed gels were stained by aniline blue black dye for 
1 hour and electrically destained. The gels were then scanned with a 
^Hycel, Inc., Houston, Texas. 
2 AO Instrument Co., Buffalo, New York. 
3 Canal CO Co., Rockville, Maryland. 
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Gilford recording densitometer^ to calculate relative percentages of each 
protein fraction. 
Plasma glycoprotein electrophoresis was performed similar to plasma 
protein electrophoresis, but the pH of tri-glycine buffer was 10.6. 
The staining for glycoproteins in acrylamide disc electrophoresis was with 
alcian blue as described by Wardi and Michos (1972). 
Blood chemical analysis 
The serum sodium (Na), potassium (K), chloride (CI), glucose, BUN, 
cholesterol, and triglycerides were determined by a Technicon auto-
2 
analyzer. The procedures were as described in automatic analyzer 
analytical methods manual. 
Blood gas tension and pH determination 
Heparinized samples of blood as described under the section on blood 
sample collection were analyzed for pH and partial pressure of Oz (POg) 
and CO2 (PCO2). The analyses were accomplished with a IL 513 pH-blood gas 
analyzer^, in addition the HCO3, Base Excess, CO2 content information was 
also included on the printout. 
Sialic acid determination 
Blood, alveolar surfactant and lung tissue were hydrolized by 5% of 
trichloracetic acid in physiological saline and incubated in 80°C water 
^Gilford spectrophotometer Model 250, Gilford Instrument, Oberlin, 
Ohio. 
2 Technicon Co., Terrytown, New York. 
3 Instrumentation Lab., Inc., Lexington, Mass. 
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bath for 1 hour. The solutions were cooled and were then centrifuged at 
400xg for 10 minutes. The concentration of sialic acid and 2-deoxyribose 
in the supernatant was determined by the autoanalyzer. The procedures are 
described by Engen et al. (1974). 
The Removal of the Lung 
As soon as the determinations of respiratory parameters were fin­
ished, the animal was totally heparinized. Then the endotracheal tube was 
connected to a Harvard respirator. The thoracic cavity was exposed by 
cutting along the sternum. After thoracotomy, the anterior and posterior 
vena cava were clamped. Physiological saline was perfused through the 
right atrium and the dorsal aorta was opened to drain blood. All blood 
was removed from the lungs by perfusion with approximately 1 liter of 
physiological saline. The whole lung was carefully isolated by clamping 
the trachea and pulmonary blood vessels. 
Observation of Gross Lesions 
The lungs were examined for gross lesions. The gross lesions in­
cluding consolidation, atelectasis and edema were recorded and photo­
graphed. 
The Lung Lavage 
The lung lavage was performed by using a three-way valve connected 
between the trachea and a 500 ml syringe. Five gentle lavages, each with 
200 ml of physiological saline were completed. Each volume of saline was 
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injected and withdrawn two times before being collected in an ice-cooled 
bottle. The total lavage fluid was 1 liter. Attempts were made to apply 
the same strength of the force and speed for flushing for all lavages. 
Collection of Pulmonary Surfactant 
The lavage fluid was centrifuged at 400xg for 15 minutes to remove 
the mucus and debris. Then the supernatant was centrifuged at 44,300xg 
for 1 hour. 
The sediment and supernatant following the second centrifugation were 
separately collected into dializing tubing and then were dialized against 
deionized distilled water at 4®C in order to remove NaCl. Completion of 
dialysis was determined by using a Barnstead purity meter^ to detect 
sodium ion. Both the sediment and supernatant were lyophilized to dryness 
2 in a freeze-dry apparatus. The dried samples were weighed and kept in 
the freezer at -30°C for further analysis (Figure 2). 
Lung Tissue Collection 
As soon as the lung lavage was finished, the lung tissue samples were 
collected. Samples from each lobe of the lung were cut into small pieces 
by scissors and were pooled together. A small volume of distilled water 
3 
was added, and the lung tissue was further disrupted by ultrasound. The 
^Barnstead. Still and Sterilizer Co., Boston, Mass. 
2 Lyophilizer, freeze dry-5 type. Lab Con Co., Kansas City, Missouri. 
^Heat Systems Co., Melville, New York. 
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Lavage fluid (1 liter) 
centrifuged at 400 x g, 15 minutes 
Sediment containing mucus 
and debris was discarded 
Sediment 
Dialized against 
deionized distilled 
water 
Ion free sediment 
I Lyophilized 
Dried sediment 
Supernatant 
centrifuged at 
44,300 X g for 
1 hour 
Supernatant 
Dialized against 
deionized distilled 
water 
Ion free supernatant 
Lyophilized 
Dried supernatant 
Figure 2. Diagram of the separation of sediment and supernatant. 
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disrupted lung tissues were lyophilized and the samples were kept in the 
freezer at -30°C for further analysis. 
Light Microscopy 
The small pieces of lung tissue were fixed in 10% buffered formalin 
for at least 10 days, dehydrated in ethanol, cleared in chloroform, and 
embedded in paraffin. Tissues were sectioned and stained with hema-
toxylin-eosin. This stain was useful for identification of the lesion 
areas. The slides were examined and photographed. 
The Protocol for Experiment 2 
The pigs were divided into two groups with examination of the first 
group at the fourth week and second at the fifth week post inoculation 
with M. hyopneumoniae (Figure 3). 
The Procedure for Studies of ^**0 Incorporated 
into Phospholipid Synthesis in the Lung 
Palmitic acid-^^C, specific activity 750 mci/iranole, molecular weight 
256.4 was purchased from New England Nuclear Corp., Boston, Mass. All 
carbons were labeled: 
*CH3(*CH2)i4*C00H 
The radiochemical purity of palmitic acid-^^C was greater than 98 
percent. The palmitic acid-i*C with a total radioactivity of 300 uci was 
dissolved in 10 ml of 0.00012 N NaOH to give a stock solution of sodium 
palmitate containing 300 uci/lO ml. Prior to its use, this solution was 
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diluted one in ten with 5% bovine albumin solution. The final solution of 
100 ml contained ^"*0 radioactivity 300 uci. 
The Administration of Sodium Pal mi ta te-^**0 into Animals 
The studies of the incorporation of pal mi ta te-into phospholipid 
of pulmonary surfactant and lung tissue were performed in young pigs at 
the fourth and fifth week post infection with Mycoplasma hyopneumoniae. 
Both infected and control animals were anesthetized with 30 mg/kg intra­
venous sodium pentobarbital. The pal mi ta te-1 uci/kg was injected via 
femoral vein. At 5 hours after intravenous injection of palmitate-^^C the 
animal was killed to collect lavage fluid, blood, serum, and lung tissue. 
The methods of collecting these samples were similar to the Experiment 1 
as described previously. 
The Counting of Radioactivity 
One ml of serum was hydrolized with 10 ml of instagel* for overnight 
and then was ready for ^"*0 counting. The individual phospholipid spots 
from their layer chromatography plates were mixed with 10 ml instagel. 
Twenty mg of dried sedimented pulmonary surfactant and lung tissue 
were hydrolized with 1 ml of toluene-250^ at room temperature for an hour 
with intermittent shaking. The clear solution was diluted to 10 ml with 
fluor solution, containing 0.1 gm of POPOP (1,4-bis-2-(4-methyl-5-phenyl-
^Instagel, Packard Instrument Co., Downers Grove, Illinois. 
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Pigs inoculated 
Mycoplasma hyopneumoniae 
Period 1-4 weeks Period 2-5 weeks 
Number of 
treated animals 
Number of 
control animals 
Symptomatic and 
gross observation 
Blood chemistry 
Phospholipid synthesis 
studies used i'*C 
Lung lavage 
post inoculation 
+ 
+ 
+ 
+ 
post inoculation 
+ 
+ 
+ 
+ 
Figure 3. Outline of the general plan of study in Experiment 2. 
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oxazolyl)-benezene) and 5 gm of PPO (2,5-diphenyloxazole), per liter of 
toluene. 
Radioactivity measurements were made using a three channel Tricarb 
liquid scintillation spectrometer (model 3375) J The labelled in each 
vial was counted for a 10 minute period. Quench corrections were made 
with an external i^^Cs reference source and a quenched sample series 
appropriate for the range of quenching in the samples. Counting effi­
ciency for ^**0 in blood, sediment, lung tissue samples were of the order 
of 64.77±0.50, 81.46±0.25, 79.47+0.17 percent, respectively. Standards 
with known quench values were included with all counting runs to insure 
correct quench corrections. 
Phospholipid Analysis 
Lipid extract 
The freeze-dried samples of pulmonary surfactant and lung tissue were 
extracted twice with chloroform-.methanol (2:1, V/V). The volume of ex­
tracted lipids was reduced by warming the extract in water bath to 38°C 
and evaporating the solvents under nitrogen. The samples were re-
dissolved in 2 ml of chloroform:methanol (1:1, V/V). 
Phospholipid fractionation 
Fifty microliters of each lipid extract sample were applied with a 
2 
micropipette to silicon gel Prekote absorbent plates along a transverse 
^Spectrometer, Packard Instrument Co., Downers Grove, Illinois. 
O 
Adsorbosil TLC plate. Applied Science Lab., Inc., Pennsylvania. 
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line 2.5 to 3.0 cm from the bottom. Application of 50 micrograms of the 
reference mixture containing dipalmitoyl-L-a-lecithin, phosphatidyl 
ethanolamine, sphingomyelin and lysolecithin^ was made to the same plate. 
The development of the chromatogram of phospholipid references and 
unknowns was performed at room temperature using chloroformrmethanol: 
water, 80:25:4 (V/V). The chromatographic chambers were prepared 20 
minutes prior to insertion of the plates. The chromatogram was allowed to 
develop until the solvent front reached 18 cm from the origin; this re­
quired about 1 hour. The phospholipids were identified by iodine 
vaporization in a dessicator. 
The Microdetermination of Phosphorus 
The samples of alveolar surfactant, lung tissue, and the spots of 
phospholipid from thin layer chromatography were analyzed for phosphorus 
as described by Morrison (1964). 
The Gravimetric Determination for Total Lipid 
The gravimetric determinations were made with 1 ml aliquot of lipid 
extract. The samples were evaporated in hand-shaped aluminum foil cups 
brought to constant weight. The cups were heated at 90°C for 20 minutes, 
transferred to a dessicator and weighed when cool. 
^Standard phospholipids, Sigma Chemical Co., St. Louis, Missouri. 
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Fatty Acid Methyl ation 
The methylation was carried out by the method of Morrison and Smith 
(1964) using Boron trifluoride as the catalyst and MeOH as the trans-
methylating agent. Total lipid extracts were methylated by using 1 ml 
aliquants. The samples were evaporated to dryness under nitrogen in 
Teflon-lined screw cap culture tubes, and then were taken up in 1 ml of 
methylating solvent mix (14% BF3 in MeOH, using 1 ml of reagent for 4-16 
mg of lipid). The tube was heated in boiling water for 2 minutes. After 
methylation, the samples were cooled and treated with two volumes of 
Pentane and one volume of water, mixed briefly and centrifuged until the 
layers were clear. The Pentane layer, containing the fatty acid methyl 
esters, was concentrated for injection into a gas liquid chromatograph. 
Gas Liquid Chromatography 
Fatty acid methyl esters were analyzed using a Beckman GC-72-B 
chromatograph.^ The instrument is equipped with dual flame ionization 
detectors. Conditions for the analysis were as follows: stainless steel 
column 10' by 1/8", packed with 3% ethylene glycol succinate on gas-chrom. 
GlOO/120 mesh HP; column temperature 180°C, injection temperature 200°C, 
detector line temperature 210°C, detector temperature 250°C, carrier gas 
flow 30 ml/min. 
The commercial standards of fatty acids were obtained from Applied 
Science Lab. and the uncorrected peak areas were determined using an 
^Beckman Co., Fullerton, California. 
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Infotronics Automatic Digital Integrator Model CRS-208.^ The relative 
percentage of each fatty acid component was calculated. 
The Determination of Protein Content 
Each sample of pulmonary surfactant sediment, pulmonary supernatant 
sediment and lung tissue was analyzed for percent of protein content by 
the method of Lowry et al. (1954). Bovine serum albumin was used as a 
standard. 
Statistical Analysis 
In Experiment 1 data was collected at the 4th, 5th or 6th week post 
inoculation with M. hyopneumoniae. In Experiment 2 data was obtained only 
at the 4th and 5th week post inoculation. Both experiments were designed 
as a two way analysis of variance (Ostle and Mensing, 1975). 
Analysis of variance table for Experiment 1. 
SV DF SS MS F 
Total 31 
T reatment 1 
Period 2 
Treatment x 
period 2 
Error 26 
^Infotronics Corporation, Austin, Texas. 
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Analysis of variance table for Experiment 2 
SV DF SS MS F 
Total 15 
T reatment 
Period 
Treatment x 
period 1 
Error 12 
The student t test was used for the comparison between the control 
and treated animals at each time period. The means of the percentages of 
the following factors were analyzed: 
1. Fatty acids of sedimented surfactant. 
2. Plasma protein fractions. 
3. Differential white blood cell count. 
4. Phospholipid composition of the lung and sedimented surfactant. 
5. The distribution of palmitate-^^C in phospholipid fractions of 
lung and sedimented surfactant. 
Figure 5. Recorder output. 
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RESULTS 
Experimental Design 
Experiment 1_ 
This experiment was a study of physiopathogenesis. Thirty-two 
specific-pathogen-free (SPF) pigs, 19 experimental and 13 control animals, 
were used. The experimental animals were inoculated intratracheally with 
M. hyopneumoniae. Physiological and post mortem studies were conducted on 
both experimental and control pigs at the 4th, 5th and 6th week post 
inoculation. 
Experiment Z 
This experiment was designed to study the effect of M. hyopneumoniae 
infection on phospholipid synthesis. It involved a total of 16 specific-
pathogen-free pigs, 8 experimental and 8 control animals. The experi­
mental pigs were inoculated intratracheally with M. hyopneumoniae. The 
studies were performed at 4th and 5th week post inoculation. 
Clinical Signs 
The only clinical sign of infection that was observed with the 
inoculated pigs was coughing. Coughing did not occur in all infected 
pigs. When it did occur coughing appeared early, frequently at about two 
weeks after inoculation, in the infected group and was prolonged until the 
6th week of the experiment. However, the infected pigs showed normal be­
havior of eating and drinking and normal general appearance. The 
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respiratory movements of inoculated pigs were normal. No nasal discharge 
was evident and the body temperature was normal. 
Gross Lesion 
Gross pneumonic lesions had already developed as early as 4th week of 
infection. The lesions were frequently confined to the apical, cardiac, 
and intermediate lobes, and the upper part of diaphragmatic lobe. The 
purple to grey colored areas of consolidation were demarcated clearly from 
the normal lung tissue. There were signs of edema throughout the lung but 
the diaphragmatic lobes were especially edematous. All of the inoculated 
pigs showed the gross pneumonic lesions (see Figures 7 and 9). There were 
no lesions in the lung of control pigs. 
Light Microscopy 
There was hyperplasia of peribronchiolar and perivascular lymphoid 
tissue, alveolar interstitial thickening, accumulation of the leukocytes 
and cellular debris in the lumen of the bronchi, and distension of the 
peribronchial glands with cellular exudate. The leukocytes extensively 
invaded the alveoli. The muscularis mucosa was ruptured and catarrh of 
bronchial cells occurred (see Figures 9, 10, 11, 12, 13, 14). 
Serology 
The microtitration complement-fixation test was performed on serum 
samples from both control pigs and pigs intratracheally inoculated with 
M. hyppneumoniae. At the 4th week of infection sera from the infected 
Figure 7. Gross pneumonie lesion from a pig infected intratracheally 
with broth culture of M. hyopneumoniae at 6th week post 
inoculation. 
Figure 8. Gross pneumonic lesion from a pig infected intratracheally 
with broth culture of hyopneumoniae at 6th week post 
inoculation. 
S«S5ë! 
Figure 9. The tertiary bronchiole and alveoli in control pigs. 
Hematoxylin and eosin stain, 158X. 
Figure 10. The secondary bronchiole and alveoli in control pigs. 
There is no lesion. Hematoxylin and eosin stain, 394X. 

Figure 11. Lung of pig 6 weeks after M. hyopneumoniae intratracheally 
exposure. The bronchus contains leukocytes and cellular 
debris. Leukocytes already infiltrated the alveoli. Hema­
toxylin and eosin stain, 158X. 
Figure 12. Peribronchial glands were distended with cellular exudate, 
leukocytes, and cellular debris filled the lumen of the 
bronchus. Hematoxylin and eosin stain, 158X. 
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Figure 13. Lung section of an inoculated pig showing peribronchiolar 
lymphoid hyperplasia (arrow), bronchus containing leuko­
cytes and cellular debris, and edematous area, at 6th week 
post infection. Hematoxylin and eosin stain, 158X. 
Figure 14. Lung section of an inoculated pig at 6th week post infec= 
tion demonstrated invasion of alveoli by leukocytes, 
rupture of muscularis mucosa (arrow) of bronchus, and 
catarrhal of bronchus cells. Hematoxylin and eosin stain, 
158X. 

81 
pigs had antibody titers between 1:16 to 1:64, with most of the sera from 
infected pigs showing a titer of 1:32. The titers of sera from the pigs 
at the 5th week of infection were between 1:16 to 1:64, with a titer of 
1:64 dominant among the animals of the group. The antibody titers at the 
6th week post infection were between 1:10 and 1:32, with 1:32 as the most 
prevalent titer. 
For Experiment 2 sera from most of the infected animals showed an 
antibody titer of 1:8 and 1:32 for the 4th week and 5th week of infection, 
respectively (Table 1). 
Body Weight Gain 
At the start of the experiment, the pigs of the control and treatment 
groups were uniform in body weight. For the control group, there was no 
statistical difference in the rate of body weight gain among the pigs in 
the three periods of trial. The infected pigs showed a marked decrease in 
rate of body weight gain in each of three periods. The body weight gain 
per day decreased by 9.50, 7.31, and 14.67 percent of that of the control 
pigs at 4th, 5th and 6th week of infection, respectively (Table 2). There 
was a significant difference (P<0.01) of body weight gain among pigs in 
the three periods of experiment. 
Body Temperature, 0% Consumption, Heart Rate 
and Respiratory Rate 
The control and the infected animals showed a normal body temperature 
of about 102.2°F for all periods. There were little changes in the heart 
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Table 1. CF titer of antibodies against M. hyopneumoniae in pigs inocu­
lated by intratracheal injection 
Experiment 1 Experiment 2 
Week post Week post 
Pig No. inoculation Titer Pig No. inoculation Titer 
913 4 1:32 933 4 1:16 
908 4 1:16 934 4 1:8 
916 4 1:32 935 4 1:8 
914 4 1:64 936 4 1:8 
917 4 1:32 
786 4 1:32 
912 5 1:64 931 5 1:32 
915 5 1:64 938 5 1:16 
791 5 1:32 932 5 1:32 
921 5 1:32 937 5 1:32 
919 5 1:64 
906 5 1:16 
798 6 1:16 
794 6 1:32 
800 6 1:32 
795 6 1:16 
922 6 1:32 
923 6 1:32 
905 6 1:32 
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Table 2. Body weight, and body weight gain per day of control and ex­
perimental pigs 
Initial 
Body wt Body wt gain* 
(kg) (gm/day) 
4th week of infection 
Control (4)® 35.68±2 .16^ 657.95±30.23 
Infected (6) 35.11+1 .44 595.46±18.45 
5th week of infection 
Control (4) 32.73±1 .54 564.78±25.40 
Infected (6) 31.90±1 .10 523.49±33.18 
6th week of infection 
Control (5) 32.64+2 .04 476.36±31.73 
Infected (7) 27.53±1 .24 406.50+24.07 
^Number of observations. 
values are meaniSEM 
•Difference among 3 periods was significant at P<0.05. 
rates and respiratory rates. The mean values of heart rate varied from 
138 to 194 beats per minute and respiratory rates varied from 18 to 22 
breaths per minute. The infected pigs showed a highly significant de­
crease (P<0.01) in oxygen consumption. The control pigs consumed 8.78, 
9.25 and 9.46 ml/min/kg of oxygen while the infected pigs consumed 6.98, 
7.48 and 7.54 ml/min/kg of oxygen at 4th, 5th and 6th week post infec­
tion, respectively (Table 3). 
Table 3. Body temperature, 0% consumption, heart rate, and respiratory rate of control and infected 
pigs 
Body temp. (°F) O2 consumption^^ (ml/min/kg) 
HR 
(beat/min) 
RR 
(Breaths/min) 
4th week of infection 
Control (4)® lO2.ltO.45b 8.78+0.33 159+11 21+1.0 
Infected (6) 102.U0.33 6.98±0.37 138+5 18+0.5 
5th week of infection 
Control (4) 102.2+0.14 9.25±0.24 183+15 20+1.0 
Infected (6) 102.4+0.20 7.48+0.14 194+14 22±2.0 
6th week of infection 
Control (5) 102.6±0.17 9.46+0.58 174+13 18±0.4 
Infected (7) 102.2±0.30 7.54±0.32 178+11 19±0.9 
^Number of observations. 
'^Values are mean±SEM. 
••Difference between control and infected pigs was significant at P<0.01. 
85 
The Change of Respiratory Parameters 
There were the significant increases (P<0.01) in tidal volume in in­
fected animals. The inspiratory flow rate was also increased in the in­
fected pigs but failed to show the significant difference from control 
pigs. There were significant increases (P<0.01) in expiratory flow rate, 
minute volume, and alveolar ventilation in the infected pigs (Table 4). 
Most likely there were drastic changes in the mechanics of breathing and 
these effects extended through all three periods of infection. The nega­
tive esophageal pressure of infected pigs was increased to twice 
that of the control pigs, which is a significant difference at P<0.01. 
The dynamic lung compliance decreased in infected pigs (P<0.07). The air­
way resistance of infected pigs showed a marked increase over that of the 
control pigs. The work of breathing was increased significantly in in­
fected pigs {P<0.01) both when work was compared as gm-m/kg and when it 
was compared as gm=m/min/kg (Table 5). 
Arterial pH, PaOz, PaCOz, HCOâ, Base Excess, P^Oz, P^COz 
The pH of arterial blood ranged between 7.35 and 7.37 for control 
pigs and between 7.31 and 7.33 for the infected pigs. The PaOz varied 
between 72 and 75 mmHg for control animals, while that for the infected 
pigs ranged between 66 and 68 mmHg. The mean values of PaCOz in control 
pigs ranged from 46 to 49 mmHg. The infected pigs showed a slight de­
crease with PaCOz varying between 42 and 45 mmHg. The decreases in 
arterial HCOâ of infected pigs were correlated with the decreases in PaCOz 
(Table 6). There were highly significant decreases of base excess (BE) 
Table 4. Tidal volume, inspiratory and expiratory flow rate, minute volume, and alveolar ventila­
tion of control and infected pigs 
Tidal Inspiratory Expiratory Minute Alveolar 
volume** flow flow** volume** ventilation** 
(ml) (L/min) (L/min) (ml) (ml) 
4th week of infection 
Control (4)® 158±5^ •|3.75±0.80 20.4510.69 3342±90 1675±43 
Infected (6) 223±9 20.42±2.12 30.67±0.72 4029±249 2633±184 
5th week of infection 
Control (4) 179±3 15.1 Oil.00 21.63+1.43 3617±257 2166±210 
Infected (6) 222±8 16.83±1.50 28.00+1.24 4870±396 3448+242 
6th week of infection 
Control (5) 177±4 14.74±0.85 21.96+1.25 3266+146 1945+123 
Infected (7) 255±9 20.00+2.37 27.43+1.36 4879+287 3721±247 
^Number of observations. 
'^Values are mean±SEM. 
••Difference between control and infected pigs was significant at P<0.01. 
Table 5. Esophageal pressure, dynamic lung compliance, airway resistance, work of breathing, of 
control and infected pigs 
PE** (cm H2O) 
, Cdyn (ml/cm H2O) 
RA 
(cm HzO/L/sec) 
Work of 
breathing** 
(gm-m/kg) 
Work of 
breathing** 
(gm-m/kg) 
4th week of infection 
Control (4)® -6.46±0.8lb 25.36+2.42 18.82+1.84 0.03+0.01 0.60±0.06 
Infected (6) -12.13+0.79 19.03±1.99 23.77±1.60 0.08±0.01 1.39+0.09 
5th week of infection 
Control (4) -6.97+0.58 26.30±2.67 19.8U2.57 0.04±0.00 0.79±0.11 
Infected (6) -11.79+1.20 19.76±1.85 25.71±3.13 0.08±0.01 1.75±0.13 
6th week of infection 
Control (5) -7.48+0.68 24.40+2.09 21.10±2.94 0.04±0.01 0.77±0.11 
Infected (7) -14.09±0.90 18.45±1.18 31.08+2.06 0.13±0.01 2.53±0.27 
^Number of observations. 
'^Values are mean+SEM. 
••Difference between control and infected pigs was significant at P<0.01. 
Table 6. The measurement of blood pH, PaOz, PaCOz, HCOj, BE, C O z  concentration and alveolar 0%, 
alveolar CO2 in control and infected pigs 
pH 
PaOz 
(mmHg) 
PaCOz 
(mmHg) 
0
 cr BE** (mEq/L) 
CO2 conc. 
(mEq/L) 
PAO2 
(mmHg) 
PACO2* 
(mmHg) 
4th week of infection 
Control (4)* 7.35+0.03b 75±4 46+4 24.80+1.00 0.10+1.39 26.25±1.07 101±2 40±1 
Infected (6)  7.3U0.04 67+2 42+1 20.87±2.24 -4.35±0.77 22.13+2.09 112+3 32±2 
5th week of infection 
Control (4) 7.35±0.04 72±6 47+4 26.13+3.16 1.63+2.70 27.63+3.25 114±3 34±2 
Infected (6) 7.32±0.04 66±1 43±2 21.95±1.34 -3.50±1.80 23.23+1.35 112±3 31 ±2 
6th week of infection 
Control (5) 7.37+0.01 75+1 49±1 27.24+0.73 3.08±0.39 29.24±0.53 93+6 45±3 
Infected (7) 7.33+0.02 68±5 45+1 22.99+0.55 -2.31+0.74 24.39±0.56 109±4 33±2 
^Number of observations. 
^Values are meaniSEM. 
•Difference between control and infected pigs was significant at P<0.05. 
••Difference between control and infected pigs was significant at P<0.01. 
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in the infected pigs (P<0.01). The concentration of CO2 in the arterial 
blood showed a decrease in infected pigs as correlated to PaCO (Table 6). 
The alveolar CO2 partial pressure showed a significant decrease (P<0.05) 
in the infected animals while the alveolar O2 partial pressure did not 
change (Table 6). 
Hb, PCV, RBC and WBC 
There were slight increases in Hb and PCV in the infected pigs. The 
increase in RBC counts tended to parallel the PCV values (Table 7). The 
mean values of total WBC in control pigs varied from 13.50 x 10' to 
17.06 X 10^ per Cmm. The counts were higher in infected pigs and varied 
between 18.23 x 10® and 19.81 x 10^ per Cmm. However, there were no 
significant differences of Hb, PCV, RBC and WBC between the control and 
infected pigs (Table 7). 
Differential Leukocyte Counts 
The percent of neutrophils increased while the percent of lymphocytes 
decreased in the infected pigs. Monocyte and eosinophil number increased 
slightly in the infected pigs. The number of basophils increased in the 
infected pigs but these cells were nearly absent in control animals (Table 
8 ) .  
Plasma Protein and Glycoprotein Fractions 
There were a number of distinct bands of plasma protein as shown 
in the electrophoresed gels (Figures 15, 16, 17). These bands were 
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Table 7. Hemoglobin (Hb), packed cell volume (PCV), red blood cells 
(RBC), white blood cells (WBC) in control and infected pigs 
Hb PCV RBC WBC 
(gm/100 ml) (%) # X 10*/cmm # X 10*/cmm 
4th week of infection 
Control (4)® 11.83+0.68^ 35+1 8.16+0.33 14.90±1.51 
Infected (6) 12.52±0.49 37±2 7.83+0.26 18.43+1.28 
5th week of infection 
Control (4) 10.53+0.29 32+1 7.05+0.15 13.50+1.39 
Infected (6) n.40±0.38 36+1 7.19+0.46 18.23+0.51 
6th week of infection 
Control (5) 10.32±0.18 33±1 6.67±0.42 17.06+1.94 
Infected (7) 10.53+0.26 33+1 6.95±0.56 19.81±0.60 
^Number of observations. 
^Values are meaniSEM. 
classified into albumin, alpha (ai, az), beta (B)» and gamma (y i , 72). 
The increase of globulin fractions occurred from 4th week through 6th 
week of infection (Table Bl). This resulted from significant increase in 
gamma globulin levels in the infected pigs. Alpha 1, alpha 2, beta 
globulin levels also showed slight increases in the infected animals 
(Figure 18). There were significant increases (P<0.01) in the total 
plasma protein in all infected pigs (Table 81). 
The plasma glycoproteins appeared on only one band in both control 
and infected pigs (Figures 19, 20 and 21). A marked increase in density 
Table 8. The percent of differential white blood cells in control and experimental pigs 
Neutrophil 
% 
Lymphocyte 
% 
Monocyte 
% 
Eosinophil 
% 
Basophil 
% 
4th week of infection 
Control (4)® 28.50+0.65^ 68.50+1.19 2.50+0.65 1.50±0.29 -
Infected (6) 31.33+6.47 62.50±5.63 3.67+0.61 2.20+0.58 1.67±0.67 
5th week of infection 
Control (4) 26.75±6.49 67.75±6.84 4.25±1.10 1.50+0.50 l.OOtO.OO 
Infected (6) 30.50±4.04 57.83±4.18 4.50+0.76 2.33±0.61 1.25±0.25 
6th week of infection 
Control (5) 25.00±1.73 70.00±0.63 3.40+0.60 2.00±0.58 -
Infected (6) 33.14±5.95 59.57±5.75 4.43+0.61 1.29+0.29 1.0010.00 
^Number of observations. 
^Values are mean±SEM. 
Figure 15. The electrophoretic separation of plasma protein at 4th 
week of hyopneumoniae infection. 
Figure 16. The electrophoretic separation of plasma protein at 5th 
week of hyopneumoniae infection. 
Figure 17. The electrophoretic separation of plasma protein at 6th 
week of M. hyopneumoniae infection. 
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Figure 18. Mean values of plasma protein fractions and total proteins in the experimental and 
control groups of 4th, 5th, and 6th week post infection of M. hyopneumoniae. 
Figure 19. Electrophoretic separation of plasma glycoprotein at 4th 
week of hyopneurnoniae infection. 
Figure 20. Electrophoretic separation of plasma glycoprotein at 5th 
week of M. hyopneurnoniae infection. 
Figure 21. Electrophoretic separation of plasma glycoprotein at 6th 
week of M. hyopneurnoniae infection. 
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of glycoprotein band in infected plasma was noted. At the 6th week of 
infection, there appeared to be more than one band of glycoprotein in the 
electrophoregram in plasma from infected pigs (Figure 21). 
Serum Electrolytes, Glucose, BUN, Cholesterol and 
Lung Weight of Animals in Experiment 2 
Concentrations of serum Na, K, CI, glucose and cholesterol were some­
what variable among all animals. The mean values are shown in Table 9. 
There are no significant differences between the concentration of each 
substance for the control and that for the infected animals. The concen­
tration of blood urea nitrogen (BUN) showed significant decreases (P<0.01) 
in the infected pigs. The lung weight of infected pigs per kg body weight 
was much greater than that of the control animals (Table 9). 
Lavaged Materials from Lungs 
The lavaged material from the lungs was collected in one liter of 
lavage fluid. This was separated into two parts by centrifugation, the 
sedimented surfactant and the supernatant fraction (Figures 22 and 23). 
The amount of sedimented surfactant and supernatant fraction were signifi­
cantly increased (P<0.01) in infected pigs over that of control animals. 
The total amount of dried lavaged materials extracted from the lungs of 
control pigs varied from 228 to 266 mg per liter of lavage fluid, while 
that from the lungs of the infected pigs varied from 490 to 519 mg per 
liter of lavage fluid (Table 10). 
Table 9. The serum Na, K, CI, glucose, BUN, cholesterol and total lung weight of control and 
experimental pigs 
Na 
(mEq/L) 
K 
(mEq/L) 
CI 
(mEq/L) 
Glucose 
(mg/100 
ml) 
BUN** 
(mg/100 
ml) 
Cholesterol 
(mg/100 ml) 
Lung wt. 
(gm/kg 
body wt.) 
4th week of infection 
Control (4)® 134.00 
±1.47b 
5.95 
±0.12 
99.75 
±0.50 
96.75 
±2.69 
13.50 
±0.87 
103.00±1.29 9.62 
±0.14 
Infected (4) 135.25 
±1.93 
6.03 
±0.17 
100.00 
±1.41 
91.75 
±5.66 
9.75 
±0.49 
93.75±3.71 18.73 
±0.90 
5th week of infection 
Control (4) 139.25 
±0.75 
6.30 
±0.09 
100.50 
±0.96 
82.25 
±4.23 
17.50 
±1.26 
97.00±3.87 10.81 
±0.50 
Infected (4) 135.75 
±1.31 
5.78 
±0.22 
99.75 
±0.48 
89.50 
±5.98 
10.25 
±0.63 
96.50±2.22 19.49 
±6.0 
^Number of observations. 
^Values are meantSEM. 
••Difference between control and infected pigs was significant at P<0.01. 
Figure 22. The general appearance of lyophilized sediment sur­
factant of control and infected pigs. 
Figure 23. The general appearance of lyophilized supernatant fraction 
of control and infected pigs. 
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Table 10. The amount of precipitate surfactant, supernatant fraction and 
total lung lavage materials from one liter of lavage fluid from 
control and infected pigs 
Sediment 
surfactant** 
(mg) 
Supernatant 
fraction** 
(mg) 
Total** 
(mg) 
4th week of infection 
Control (4)® 177119^ 82±11 259±15 
Infected (6) 247+14 243±34 490±45 
5th week of infection 
Control (4) 147+12 82±10 228+17 
Infected (6) 221±20 298±37 519±54 
6th week of infection 
Control (5) 172+9 93+12 266+15 
Infected (7) 207±7 297+59 504±62 
^Number of observations. 
^Values are means+SEM. 
**A11 differences between control and infected pigs were significant 
at P<0.01. 
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The Chemical Composition of Lavaged Materials from the Lungs 
The protein composition 
The protein content in the sedimented surfactant from the lungs of 
control pigs varied from 53 to 58 percent, and that from the lungs of the 
infected pigs varied from 55 to 61 percent. The protein content of the 
supernatant fraction ranged from 54 to 67 percent in the lavage material 
from control pigs, while marked increases from 80 to 86 percent were ob­
served in the lavage material from infected pigs. However, the percent of 
protein in lung tissue itself was 17 percent with no changes following in­
fection (Table 11). 
The electrophoretic separation of the proteins in the supernatant 
fraction showed at least five components. An additional band which 
migrated ahead of the albumin fraction (reference) was distinguishable as 
shown in Figures 24, 25 and 26 in the control and experimental group. 
The total lipid composition 
The lipid content of the sedimented surfactant of the lungs of con­
trol pigs varied from 27 to 31 percent while that of the infected pigs 
varied between 22 and 28 percent (Table 12). The total lipid content of 
supernatant fraction of the lungs of control pigs showed mean values be­
tween 20 and 22 percent. There were significant decreases to 3 and 4 
percent (P<0.01) in total lipid in the supernatant fraction from lungs of 
infected pigs. The total lipid content of lung tissue was fairly constant 
with mean values ranging between 20 and 22 percent (Table 12). 
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Table 11. The protein composition in percent of dry matter of sediment, 
supernatant, lung tissue 
Sediment Supernatant Lung tissue 
% % % 
4th week of infection 
Control (4)® 53+3^ 55±1 16+0.00 
Infected (6) 61 ±2 80±3 17+0.33 
5th week of infection 
Control (4) 56±2 67±3 17±0.48 
Infected (6) 59+3 86+4 17±0.50 
6th week of infection 
Control (5) 58±3 54±3 17±0.37 
Infected (7) 55+3 86+2 17±0.31 
^Number of observations. 
"Values are meaniSEM. 
Fatty Acids Pattern of Sediment Surfactant 
There were both saturated and unsaturated fatty acids including 
myristic acid (14 carbon), palmitic acid (16 carbon), and stearic acid 
(18 carbon) in the pulmonary sediment surfactant. The fatty acid com­
ponent present in the greatest concentration was palmitic acid which 
showed the mean of total percent varied between 70.34 and 76.65 in control 
pigs (Figures 27, 28, and 29). The rest of the other fatty acids varied 
between 2.52 and 11.63 percent (Table B2). The percent of saturated fatty 
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Table 12. The total lipid composition in percent of dry matter of sedi­
ment, supernatant, and lung tissue of control and infected pigs 
Sediment 
surfactant 
% 
Supernatant 
fraction** 
% 
Lung 
tissue 
% 
4th week of infection 
Control (4)^ 30+4^ 20+3.0 22+1 
Infected (6) 22+2 4±0.5 21+1 
5th week of infection 
Control (4) 31±3 22±6.0 20±1 
Infected (6) 27±3 4+1.0 22+1 
6th week of infection 
Control (5) 27±4 22±4.0 20+1 
Infected (7) 28+3 3±0.3 20±1 
^Number of observations. 
^Values are mean SEM. 
**Difference between control and infected pigs was significant at 
P<0.01. 
acids tended to decrease during infection. The percent of unsaturated 
fatty acids tended to be elevated in the infected pigs (Table B2). The 
differences, however, were not significant. The mean ratio of total 
saturated fatty acid:unsaturated fatty acids was 3.79:1, 6.31:1, and 
5.19:1 for control pigs at 4th; Sth, 6th week post inoculation. The mean 
saturated:unsaturated fatty acids ratio decreased to 3.12:1, 4.22:1 and 
Figure 24. The electrophoretic separation of protein from 50 ul of 
supernatant fraction (25 mg/ml) of pigs at 4th week of 
hyopneumoniae infection. 
Figure 25. The electrophoretic separation of protein from 50 ul of 
supernatant fraction (25 mg/ml) of pigs at 5th week of 
hyopneumoniae infection. 
Figure 26. The electrophoretic separation of protein from 50 ul of 
supernatant fraction (25 mg/ml) of pigs at 6th week of 
hyopneumoniae infection. 
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Figure 27. Fatty acid pattern of pulmonary surfactant (sediment) from M. hyopneumoniae infected 
pigs at 4th week of infection. 
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Figure 28. Fatty acid pattern of pulmonary surfactant (sediment) from M. hyopneumoniae infected 
pigs at 5th week of infection. 
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Figure 29. Fatty acid pattern of pulmonary surfactant (sediment) from M. hvopneumoniae infected 
pigs at 6th week of infection. 
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4.18:1 for infected pigs at 4th, 5th and 6th week post infection, respec­
tively. 
Phospholipids Composition of Sediment 
Surfactant and Lung Tissue 
The sediment surfactant 
The fractionation of phospholipids in the sediment surfactant by 
thin layer chromatography (Figures 30 and 31) showed that lecithin was the 
major component, with the mean of percent variation between 79.7 and 81.79 
for control pigs. No change in total lecithin occurred with infection as 
the mean percent for these pigs varied from 78.39 to 81.19. The concen­
tration of ethanolamine varied between 7.88 and 9.44 percent, and that of 
sphingomyelin and lysolecithin varied between 10.33 and 12.35 percent. 
The relative amount of ethanolamine and sphingomyelin and lysolecithin in 
the infected pigs was not different from that of the control animals 
(Figure 32, Table 13 and Table B3). In the control pigs the means of the 
total phospholipid concentration of sediment were between 232.00 and 
261.25 mg per gm of dry matter. Marked decreased which varied between 
201.50 and 222.86 mg per gm of dry matter occurred in infected pigs. 
The lung tissue 
Lecithin was the major component of the lung tissue. The means of 
the percent concentration varied between 55.44 and 55.63, with slight de­
creases in the infected pigs. The mean of percent of ethanolamine varied 
between 17.23 and 18.01 and was changed very little in the infected pigs. 
Shpingornyelin and lysolecithin had mean values which varied between 24.06 
Figure 30. The fractionation of phospholipids from 500 ugm of total 
lipid from surfactant on thin layer chromatography plate. 
The solvent system consisted of chloroform:methanol : 
water; 80:25:4. 
Figure 31. The fractionation of phospholipids from 500 ugm of total 
lipid from lung tissue on thin layer chromatography plate. 
The solvent system consisted of chloroform:methanol:water; 
80:25:4. 
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Figure 32. The percent composition of phospholipid fractions in the pulmonary surfactant 
(sediment). 
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Table 13. Phospholipid concentration of sediment surfactant and lung 
tissue of control and infected pigs 
Sediment surfactant 
(mg/gm DM) 
Lung tissue 
(mg/gm DM) 
4th week of infection 
Control (4)^ 
Infected (6) 
5th week of infection 
Control (4) 
Infected (6) 
6th week of infection 
Control (5) 
Infected (7) 
261.25±19.16r 
201.50±14.08 
232.00±24.33 
214.00±15.95 
251.80+10.58 
222.86+15.66 
158.25±5.31 
143.17±4.39 
154.00±6.22 
158.17+8.01 
166.20±9.52 
145.57+3.98 
Phospholipid concentration was calculated from the concentration of 
P X 22.88. 
Number of observations. 
'Values are mean+SEM. 
and 27.15 and were only slightly changed in infected pigs (Table B3). The 
mean total phospholipid concentration in the lung tissue was between 
150.00 and 166.20 mg per gm and tended to decrease slightly in infected 
pigs. The mean concentrations in lung tissue of infected pigs varied 
between 143.17 and 158.17 mg per gm dry matter (Figure 33, Table 13 and 
Table B3). 
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Figure 33. The percent composition of phospholipid fractions in the lung. 
116 
The Distribution of Pal mi ta te-^''C in Sediment 
Surfactant, Lung Tissue and Plasma 
The sedimented surfactant, lung tissue, and plasma were collected at 
five hours after intravenous injection of pal mi ta te-The mean of 
radioactivity of sedimented surfactant was between 1913 to 2053 DPM per 
20 mg of dry matter for control pigs. The mean values for infected pigs 
decreased to between 1610 and 1821 DPM per 20 mg dry matter. 
The mean radioactivity of the lung tissue in control pigs ranged from 
783 to 916 DPM per 20 mg dry matter. There was a decrease (P<0.01) in the 
radioactivity for the infected pigs which showed the mean values ranging 
from 573 to 590 DPM per 20 mg dry matter. The mean radioactivity of the 
plasma ranged from 342 to 350 DPM per ml for both the control animals and 
infected animals (Table 14). 
The Distribution of Radioactivity of Pal mi ta te-
Between the Phospholipid Fractions in Pulmonary 
Surfactant (Sediment) and Lung Tissue 
The means of the percent of radioactivity in lecithin component of 
the sediment were between 89.88and 90.34 for the control pigs. The radio­
activity decreased slightly in the infected pigs. The means of percent of 
radioactivity in ethanolamine component were between 4.10and 4.15 for con­
trol animals, and also showed slight decreases in the infected animals. 
The means of percent of radioactivity distribution in the sphingomyelin 
and lysolecithin components of control animals were between 5.50 and 6.04. 
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Table 14. Distribution of palmitate-^^C in sediment, lung tissue and 
plasma in DPM 
Sediment 
(20 mg) 
Lung tissue** 
(20 mg) 
PIasma 
(1 ml) 
4th week of infection 
Control (4)® 19131195^ 783±69 346±18 
Infected (4) 1821±244 573+33 350±43 
5th week of infection 
Control (4) 2053±78 916±27 342±7 
Infected (4) 1610+215 590±61 343±22 
^Number of observations. 
^Values are mean±SEM. 
••Difference between control and infected pigs was significant at 
P<0.01. 
There were slight increases in radioactivity in the infected pigs (Figure 
34 and Table B4). 
The mean of percent of radioactivity in the lecithin component of 
lung tissue was between 64.25 and 72.34 in control pigs and 64.06 and 
71.77 for infected pigs. The ethanolamine component had means which 
varied between 10.39 and 11.72 for control pigs. The radioactivity 
distribution showed marked decrease for the lecithin and ethanolamine 
components in both sediment and lung tissue. The sphingomyelin and lyso-
lecithin component showed the means varied from 5.50 to 6.04 and in the 
lung tissue were between 17.29 and 24.04 in the control animals. There 
4th week of infection 
P 
Lecithin Ethanolamine Sphingomyelin 
Lyflolecithin 
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I I control 
infected 
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Figure 34. Distribution of radioactivity between phospholipid fractions in pulmonary surfactant 
(sediment) 5 hours following the intravenous administration of ^"*0 labeled 
palmitate. 
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were slight increases of the radioactivity for the infected animals 
(Figure 35 and Table B4). 
The Total Concentration of Sialic Acid in Pulmonary 
Sediment Surfactant, Supernatant Fraction, 
Plasma and Lung Tissue 
The total amount of sialic acid was determined for the sedimented 
surfactant and the supernatant fraction obtained from one liter of lavage 
fluid. The mean values for sialic acid in dry matter of sedimented sur­
factant were between 11.37 and 17.19 mg for control pigs. Marked in­
creases were observed in the lavage material from infected pigs which 
showed the mean values ranging from 18.15 to 20.59 mg. The total amount 
of sialic acid in dry matter of supernatant fraction of lavage fluid from 
control pigs varied between 6.76 and 15.06 mg. There were significant 
increases (P<0.01) for sialic acid for lavage supernatant for the infected 
pigs. These mean values were between 41.85 and 46.64 mg. 
The sialic acid concentration in the plasma showed the means varied 
from 64.69 to 66.97 mg per 100 ml of plasma in control pigs. The infected 
pigs had mean sialic acid concentrations ranging between 65.14 and 73.18 
mg per 100 ml of plasma, with increases paralleling the duration of infec­
tion. 
The mean concentration of sialic acid in the lung tissue of both 
groups varied from 4.26 to 4.88 mg per gm of dry matter (Table 15). 
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Figure 35. Distribution of radioactivity between phospholipid fractions in lung 5 hours following 
the intravenous administration of ^**0 labeled palmitate. 
Table 15. Sialic acid concentration in sediment, supernatant, total pulmonary surfactant, plasma, 
and lung tissue 
Sediment Supernatant** Total** Plasma Lung tissue 
(mg) (mg) (mg) (mg %) (mg/gm DM) 
4th week of infection 
Control (4)* 11 .37±0 .48^ 6.76+1.33 18.13±1.73 64.69±5. 11 4.26±0.12 
Infected (6) 18 .15±1 .37 46.64±11.23 64.80±11.96 65.14±2. 14 4.43±0.13 
5th week of infection 
Control (4) 12 .66±1 .29 13.80±2.15 26.46±1.83 65.86±2. 60 4.42±0.n 
Infected (6) 20 .59+2 .06 51.98+6.85 72.57±8.44 69.00+4. 28 4.48±0.07 
6th week of infection 
Control (5) 17 .19±1 .26 15.06+2.25 32.25+3.09 66.97±1. 11 4.88+0.28 
Infected (7) 18 .48+1 .69 41.85±7.88 60.33±8.39 73.18±2. 10 4.61+0.21 
^Number of observations. 
^Values are mean+SEM. 
**Difference between control and infected pigs was significant at P<0.01. 
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DISCUSSION 
Mycoplasma h.vopneumoniae has been named and characterized as the 
causative agent for a chronic pneumonia of swine (Mare and Switzer, 1965). 
The disease is distributed worldwide and has caused an enormous economic 
loss to the swine industry as emphasized by Switzer and Ross (1975). The 
clinical signs of mycoplasmal pneumonia appear after an incubation period 
of 10-16 days and include coughing, loss of vigor, growth retardation, 
decreased efficiency of feed utilization, high morbidity and low mortality. 
These effects will be severe if there are secondary bacterial infections. 
The pathologic lesions of the lung have been well-described (Lam, 1970; 
Livingston et al., 1972; Oboegbulem, 1973). Most of the gross lesions 
occur in the infected areas of the lung resulting in atelectasis which is 
followed by consolidation. The most extensive damages of the lung 
occurred at about 28 days after intranasal inoculation (Livingston et al., 
1972). Switzer and Preston (1974) found that young growing pigs were most 
susceptible to infection. 
In this study young pigs were infected at 5 1/2 to 6 weeks of age and 
physiological studies were made. The growth rate of infected pigs was 
compared with that of the control pigs. The body weight gain of infected 
pigs decreased by 9.50, 7.31 and 14.67 percent at 4th, 5th, and 6th week 
of infection, respectively. The reduction of growth rate in mycoplasmal 
pneumonia group of swine was quite obvious in the young growing pigs. 
Coughing was observed as early as two weeks post inoculation. The 
characteristic pattern of breathing was normal and there was not respira­
tory discharge. This finding was similar to previous descriptions (Betts, 
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1952; L'Ecuyer and Switzer, 1963; Oboegbulem, 1973). There was no sig­
nificant difference in body temperature between infected and control pigs. 
There was no significant difference in either heart rate or respiratory 
rate between control and infected animals. 
Most of the gross lesions in the pneumonic lungs occurred in the 
apical, cardiac and intermediate lobes and appeared as consolidated areas 
which were well-demarcated and plum-red in color. Lesions occurred in 
the upper region of diaphragmatic lobe in many infected animals. The 
weight of pneumonic lungs per kg body weight was increased markedly and 
the lungs were edematous. The gross changes were similar in the pneumonic 
lungs of pigs at the 4th, 5th, and 6th week of infection. 
The microscopic lesions of the lung of infected pigs were similar to 
those described in many previous reports (Lam, 1970; Livingston et al., 
1972; Oboegbulem, 1973). There was hyperplasia of the peribronchial and 
perivascular cells. Leukocytes invaded the alveoli and then the lumen of 
bronchioles. The peribronchiolar lymphatic nodules were hypertrophied. 
There was a tremendous amount of exudate and secretion from the respira­
tory tract of the infected pigs. Cartarrha from peribronchiolar cells 
also was observed. It was postulated from this experiment that M. hyo-
pneumoniae caused damage to the lung structure producing atelectasis and 
eventually consolidation. The consolidated areas were dense with neither 
gas movement nor perfusion and were scattered in the apical, cardiac, 
intermediate and the upper part of diaphragmatic lobes. The infected 
lung produced a great amount of secretion as can be seen by lung lavage 
fractions. The thickening of vascular membranes and stiffness of bronchi-
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oies could contribute to the change of the respiratory parameter values. 
The results of respiratory measurements from the experiment showed the 
following changes: 
1. The infected pigs consumed significantly less oxygen, even with 
significant increases in tidal volume. The reason for this is 
the capability of gas diffusion was decreased. 
2. There were drastic increases in the expiratory and inspiratory 
flow rate of air. 
3. The minute volume and alveolar ventilation were increased 
significantly in the infected animals. Forster (1974) pointed 
out that hyperventilation is a response to an increase in body 
fluid acidity. 
The transpulmonary pressure was increased significantly in infected 
pigs. The dynamic lung compliance decreased markedly in infected pigs. 
This means that elasticity of the lung was reduced and, also, that the 
airway resistance increased. The hypersecretion of nonsurfactant sub­
stances into the lung occluded the airway causing these changes in com­
pliance and resistance. The work of breathing subsequently increased 
(PcO.Ol) in infected pigs attempting to overcome this problem. It was 
assumed that the infected pigs would spend more energy for respiratory 
compensation. As a result of M. hyopneumoniae infection, the affected 
alveolar areas collapsed (atelectasis), and the invasion of leukocytes, 
exudates and cellular debris into alveolar pores occluded the bronchi­
oles and airways. This reduced the areas available for gas exchanges. 
The infected animals showed marked increases in total lung weight and 
evidence of edema. 
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The edematous development would reduce the rate of blood flow in the 
capillary system. As a result of a poor diffusion of oxygen at the 
alveoli there was a marked decrease in partial pressure of oxygen in 
arterial blood. Whenever gas diffusion is decreased, the pH of arterial 
blood will decrease. However, in the present studies there were slight 
decreases in the pH of arterial blood and in the partial pressure of 
arterial blood PCOg to values less than those of the control animals. 
The reason for this is that the buffer system of the blood operated to 
neutralize the excess H"*" as indicated by marked decrease in the HCO3, and 
significant decreases of base excess in infected animals. The other evi­
dence of hyperventilation was significant decrease in alveolar PCO2 in 
infected animals. Infected animals attempted to decrease the PACOg level 
by hyperventilation, with the result that the alveolar PCO2 decreased 
blood pH values in most infected pigs remained near normal because of 
compensatory respiratory alkalosis (hyperventilation). West (1974) 
pointed out that a balance V/Q ratios do exist in normal lung. Kowever, 
if the perfusion is decreased, the enhancement of diffusion of gas must 
be increased so as to maintain the balance of acid-base and gas concen­
tration of blood. Therefore, it can be assumed that in the mycoplasmal 
pneumonic lung greater ventilation is required because of the reduction 
of pulmonary circulation. Pigs infected with M. hyopneumoniae could show 
possibly both poor diffusion of gas and poor circulation in the capillaries 
of the lung. 
There were no drastic changes in hematologic components in pigs with 
mycoplasmal pneumonia. No significant differences were observed between 
the infected and control animals in hemoglobin, packed cell volume, or 
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number of red blood cells. Serum electrolytes such as sodium, potassium, 
and chloride remained at a normal level. There were marked increases in 
number of white blood cells in infected animals. The leukocytes in­
creased to between 18.40 x 10® and 19.81 x 10® cells/cmm. The most 
consistent leukocyte alteration in pigs with mycoplasmal pneumonia was a 
marked increase of neutrophils and marked decrease of lymphocytes. The 
number of neutrophils increased in parallel with the increase in total 
white blood cells. Monocytes, eosinophils, and basophils also showed 
slight increases. There were transient reductions in lymphocyte counts. 
Mean total plasma protein concentrations in normal pigs ranged from 
5.25 to 5.65 gm/100 ml and in infected pigs from 6.33 to 6.53 gm/100 ml. 
Electrophoretic separation of the various fractions indicated a reduction 
in albumin and an increase in globulins. The increase in relative amounts 
of globulin resulted primarily from an elevation of alpha-2 globulin. 
However, this type of change is common in many diseases and even some 
kinds of stress could induce this result (Vesselinovitch, 1955). Hema­
tologic changes were for the most part generalized reactions to inflam­
mation. Results of respiratory parameters and blood gas analysis offered 
more information concerning the acid-base balance status in mycoplasmal 
pneumonia pigs. 
Significant increases in amount of sediment surfactant and super­
natant fraction were observed in infected animals. Phospholipids 
are the major component of pulmonary surfactant and play a major role in 
stabilization of the alveolar surface tension (Clements et al., 1958; 
Tierney et al., 1967; Scarpelli, 1968a; Clements, 1970; King, 1974). The 
results from the present experiment showed that lecithin was the major 
127 
component of phospholipids. Ethanolamine, sphingomyelin and lysolecithin 
were incorporated as minor components of total phospholipids. There was a 
slight decrease in the lecithin concentration of sediment surfactant in 
infected pigs as compared with that of normal pigs. However, the total 
amount of sediment surfactant in lavage fluid of the infected pigs showed 
a significant increase. This result could be due to an increased synthe­
sis of phospholipid to maintain the normal patent alveoli. 
Cohen and Somerson (1967) showed that Mycoplasma pneumoniae can pro­
duce hydrogen peroxide which is harmful to the host cells. The ratio of 
saturated fatty acid:unsaturated fatty acid in sediment surfactant de­
creased in the M. hyopneumoniae infected pigs. A slight reduction of 
saturated fatty acids and a slight elevation in percent of unsaturated 
fatty acids occurred. By injecting pal mi ta te-^**0 into pigs with myco­
plasmal pneumonia, it was found that there was a slight decrease of radio­
activity in sediment surfactant but a significant decrease of radioactivi­
ty in the lung tissue. The net amount of radioactivity in sediment sur­
factant from one liter of lavage fluid from infected animals was greater 
than that from the control group. This indicated an increased synthesis 
of phospholipids in infected pigs. 
Gesner and Thomas (1965) reported that sialic acid was the binding 
site of M. gallisepticum to erythrocytes and this carbohydrate plays a 
role in hemagglutination. Sobeslavsky et al. (1968) showed that sialic 
acid component of tracheal epithelial cells or blood cells was the ad­
sorption site for M. pneumoniae. Although the sialic acid content of 
sediment surfactant showed only a slight increase, there was significant 
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increase in total amount of sialic acid in surpernatant fraction of the 
lung lavage of infected pigs. An electrophoretic analysis of plasma 
glycoprotein revealed a marked increase in glycoprotein in infected pigs. 
From the results of the determination of concentration of sialic acid and 
glycoprotein in the pulmonary secretion and plasma of infected pigs, it 
would be postulated that the infected lung secreted glycoprotein contain­
ing sialic acid to prevent the attachment of Mycoplasma hyopneumoniae or 
reduce the proliferation of the number of pathogenic agents. 
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SUMMARY 
The primary concern of this research was to determine the physio­
logic changes in the lung of young growing pigs that were intratracheally 
inoculated with Mycoplasma hvopneumoniae. Hematologic changes were also 
studied. All studies were performed at the 4th, 5th and 6th week post 
inoculation of 5 1/2 to 6 week old pigs. 
The infected pigs showed marked decreases of body weight gain. There 
were no significant changes of heart rate, respiratory rate, and body 
temperature. At autopsy the apical, cardiac, intermediate and the upper 
part of diaphragmatic lobes of the lungs of infected pigs showed a scat­
tering of well-demarcated pneumonic lesions. The lungs of infected pigs 
increased in weight and developed edema. 
There were several changes in respiratory parameters in infected 
animals. The infected pigs showed a significant increase in esophageal 
pressure negativity, expiratory flow rate, tidal and minute volume, 
alveolar ventilation and work of breathing. There was significantly less 
oxygen consumption. There were marked increases of inspiratory flow rate 
and airway resistance in infected pigs. The elasticity of infected lungs 
was reduced markedly as shown by marked decreases of dynamic lung compli­
ance. 
Blood gas analyses showed that there were changes in acid-base 
balance in infected pigs. The pH of arterial blood in infected animals 
was decreased and the arterial partial pressure of O2. and CO2 and 
arterial concentration of HCO3 showed marked decreases. The blood of 
infected pigs showed some degree of respiratory acidosis as indicated by 
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significant decreases of base excess. As a result the infected animals 
operated compensatory respiratory alkalosis by increased hyperventilation 
in order to maintain the pH of arterial blood near normal. 
The pigs with mycoplasmal pneumonia showed no drastic hematologic 
changes. There were no changes in red blood cell number, packed cell 
volume, or hemoglobin. However, the total number of white blood cells 
increased markedly in infected pigs. The differential count revealed 
large increases in the number of neutrophils, small increases in number 
of monocytes, eosinophils and basophils, and slight decreases in numbers 
of lymphocytes. The total plasma protein and glycoprotein concentrations 
were increased significantly in infected animals. The electrophoretic 
separation of plasma proteins showed a significant decrease in relative 
percent of albumin and significant increase in relative percent of 
globulin fractions. Plasma glycoprotein increased markedly in infected 
pigs as well. There were no significant changes in concentrations of 
serum electrolyte such as Na+, Kî-, and Cl~. Blood glucose and cholesterol 
showed no changes. 
Special emphasis was placed on determining the changes in the lung 
surfactant system. The total amount of sediment surfactant that was 
collected by lung lavage increased significantly in the infected animals. 
The fractionation of phospholipids of sedimented surfactant on thin-layer 
chromatography indicated there were no significant differences in the 
individual phospholipids between control and infected lung. When phospho­
lipids were labeled with palmitate-i^c there was slightly less radio­
activity incorporated into the sedimented surfactant, and significantly 
less radioactivity incorporated into lung tissue of infected pigs. 
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However, there were no significant differences between control and 
infected animals in the amount of radioactivity in the plasma. 
The chemical analyses of dried lung lavage materials showed that the 
total percent of protein and lipid of sedimented surfactant were not 
significantly different between control and infected pigs. There were 
significant increases in protein concentration and decreases in total 
percent lipid in the supernatant fraction of lavage substances from the 
lungs of infected animals. 
There were significant increases in total concentration of sialic 
acid in the sedimented surfactant and supernatant fraction of the lavage. 
There was also a marked increase of sialic acid concentration in plasma 
of infected pigs. 
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APPENDIX A: ABBREVIATIONS, DEFINITIONS, AND REAGENTS 
FOR GLYCOPROTEIN ELECTROPHORESIS 
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Abbreviations 
Parameter 
Weight 
Heart rate 
Respiratory rate 
Tidal volume 
Minute volume 
Expiratory velocity 
Inspiratory velocity 
Esophageal pressure 
Lung compliance 
Airway resistance 
Work/kg 
Work/minute/kg 
rartiai pressure ui 
arterial Oz 
Partial pressure of 
arterial CO2 
pH 
hemoglobin 
Hematocrit 
Abbreviation 
Wt 
HR 
f 
MV 
"I 
^E 
Cdyn 
R* 
WK/kg 
Wk/min/kg 
PaOz 
PaCOz 
pH 
Hb 
PCV 
Unit 
Kg 
beats/mi n 
breaths/min 
ml 
ml/mi n 
L/min 
L/min 
CmHzO 
ml/cmHzO 
CmHzO/L/sec 
g-m/kg 
g-m/min/kg 
mmHg (Torr) 
mmHg (Torr) 
pH 
gm/100 ml 
percent 
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Definitions 
The definition of the respiratory parameters are defined by Comroe 
et al. (1962). 
Tidal volume (Vjj - The depth of breathing is the volume of gas inspired 
or expired during each respiratory cycle. 
Inspiratory reserve volume (IRV) - The maximal volume that can be in­
spired from end-tidal inspiration. 
Expiratory reserve volume (ERV) - The maximal volume that can be expired 
from resting expiratory level. 
Residual volume (RV) - The volume of gas in lungs at end of maximal 
expiration. 
Total lung capacity (TLC) - The volume of gas in lung at end of maximal 
inspiration. 
Vital capacity (VC) - The maximal volume that can be expired after maximal 
i nsp i rati on. 
Inspiratory capacity (IC) - The maximal volume that can be inspired from 
resting expiratory level. 
Functional residual capacity (PRC) - The volume of gas in lungs at resting 
expiratory level. 
Airway resistance (R^) - The pressure between the airway opening (i.e., 
mouth or nose) and the alveoli, in relation to simultaneous air 
flow; expressed as CmHaO/liter/sec. 
Alveolar gas - Expired gas that has come from alveoli. The definition of 
mean alveolar gas concentration is complicated by the discontinuous 
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nature of lung ventilation and perfusion, and by the nonuniform be­
havior of the lung in regard to these aspects of function. 
Alveolar ventilation - If the lungs behaved as a completely uniform sys­
tem, alveolar ventilation could be defined as the tidal volume minus 
the anatomical dead-space volume, multiplied by the respiratory 
frequency. In many situations, however, alveolar ventilation can be 
defined only in terms of the arterial PCO2, the level of which 
ordinarily reflects the total effective alveolar ventilation. 
Blood-gas tension - The pressure in mmHg of a gas in the blood. Note that 
pressures between a liquid and a gas must always be in equilibrium, 
regardless of solubility, buffer systems, partition coefficients, or 
dissociation curves. 
Compliance, dynamic (C dyn) - The ratio of the tidal volume to the differ­
ence in pressure at points of zero gas flow, expressed in ml/cmHzO. 
Dead space, anatomical (inert-gas dead space) - The volume of all nongas-
exchanging passages in the lung, normally comprising the upper airway 
and bronchial tree as far as the respiratory bronchioles. 
Work of breathing - The cumulative product of instantaneous pressure de­
veloped by the respiratory muscles and volume of air moved in a 
breathing cycle, expressed as g-m/kg. 
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Reagents for Glycoprotein Electrophoresis 
Buffer 
Glycine-NaOH buffer pH 10.6 (stock buffer was diluted 8 times 0.05 M 
for electrophoresis) 
364 ml of 1.0 M NaOH 
400 ml of 1.0 M glycine 
QS to 1 liter for 0.4 M stock buffer 
Gel 
Sol. "A" Acrylamide 30.0 grams 
N,N'-methylene-bis-acrylami de 1.0 g were suspended in 123 ml 
H2O. Mix repeatedly until most solid is in solution. A clear 
solution was obtained after filtration through a glass wool 
plug. 
Sol. "B" Stock buffer (0.4 M) indicated above, stored at 5°C. 
Sol. "C" (TEMED) N,N,N',N' - tetramethyl-ethylenadiami ne 1% sol. 1 ml in 
100 ml H2O. 
Sol. "0" Aqueous ammonium persulfate solution (0.56% w/v). 
The gels containing 5% acrylamide were obtained by adding the following 
reagents in the order indicated to 6 ml HgO in a beaker: 
4.0 ml Sol. "A" 
2.0 ml Sol. "B" 
2.0 ml Sol. "C" 
2.0 ml Sol. "D" 
After adding Sol. "D", polymerization was usually complete in 15 minutes. 
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APPENDIX B: THE ANALYSIS OF VARIANCE PLAN, 
AND OBSERVED MEAN SQUARES DATA 
Table B1. The percent of plasma protein fractions, and total plasma protein in control and infected 
pigs 
Albumin 
(%) 
Alpha 
ai «2 (%) (%) 
Beta 
6 {%) 
Gamma 
Yi Y2 (%) (%) 
Total plasma 
protein** 
(gm %) 
4th week of 
infection 
Control (4)* 49.17+1.82^ 5.42+0.72 7.i52±0.80 8.80+0.87 7.78+0.69 21.15±2.03 5.65±0.21 
Infected (6) 36.45+1.65** 5.82+0.30 10.27+0.77 10.06+0.49 9.34+0.74 27.56±1.48* 6.33+0.04 
5th week of 
infection 
Control (4) 51.08+2.71 4.07±0.35 10.21+1.22 11.45±1.04 7.53+1.49 15.67±1.54 5.25±0.13 
Infected (6) 29.53±2.11** 8.39+1.37* 11.33±0.88 11.98±1.03 8.72+1.13 30.79±2.07** 6.40+0.10 
6th week of 
infection 
Control (5) 46.09±1.30 6.64+0.83 9.88+1.13 8.95±0.83 7.46+0.80 20.99±1.60 5.42+0.17 
Infected (7) 22.68+1.46** 7.41±0.62 10.91+0.94 10.99+0.47* 12.29±1.68* 35.49+2.06** 6.53±0.10 
^Number of observations. 
'^Values are means+SEM, expressed as % of total plasma protein fraction 
•Significant at P<0.05. 
••Significant at P<0.01. 
Table B2. Fatty acid esters of sediment surfactant 
# carbon 
14 14:1 16 16:1 18 18:1 
4th week of infection 
Control (4)® 3.3710.76^ 2.96+0.74 70.34+2.12 6.96+1.83 6.00±0.84 11.13+1.52 
Infected (6) 2.44±0.30 4.82±1.84 69.91±4.07 11.63±1.51 7.76±0.37 9.24+1.32 
5th week of infection 
Control (4) 5.93±1.13 - 76.43+5.36 8.79+2.02 7.75±1.85 5.49±2.45 
Infected (6) 3.47±0.62 2.52t0.22 73.5U4.67 10.68+3.03 7.44±0.74 6.79±1.08 
6th week of infection 
Control (5) 4.50±0.79 2.72±0.98 76.65±5.06 6.34+3.65 3.42±0.92 7.23±1.67 
Infected (7) 4.47±0.53 2.97t0.15 75.90+3.01 11.06±2.35 5.60+1.43 6.52+1.03 
^Number of observations. 
^Values are mean+SEM, expressed as % of total fatty acids. 
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Table B3. The percent composition of phospholipid fraction in the sedi­
ment surfactant and lung tissue 
Sphingomyelin 
Lecithin Ethanolamine lysolecithin 
{ % )  { % )  { % )  
4th week of infection 
Sediment surfactant 
Control (3)® 81.79+0.40^ 7.88±0.21 10.33±0.32 
Infected (4) 81.19+0.52 8.25+0.40 10.55±0.50 
Lung tissue 
Control (4) 55.63±1.78 17.23+1.01 27.15±1.62 
Infected (4) 53.91+1.76 20.02±1.63 25.80±3.05 
5th week of infection 
Sediment surfactant 
Control (3) 79.07+1.58 9.44±0.83 11.48+0.80 
Infected (4) 78.39+4.32 9.27+1.77 12,35+2.57 
Lung tissue 
Control (4) 55.44+0.31 18.01+1.35 24.06±1.93 
Infected (4) 54.83+0.72 19.87±1.06 25.31+0.99 
^Number of observations. 
^Values are mean±SEM, expressed as % of total phospholipid. 
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Table B4. Distribution of radioactivity between phospholipid fractions in 
sediment surfactant and lung tissue 
Lecithin 
(%) 
Ethanolamine 
(%) 
Sphingomyelin 
lysolecithin 
(%) 
4th week of infection 
Sediment surfactant 
Control (3)® 90.3410.47^ 4.15+0.31 5.50+0.27 
Infected (4) 89.59+0.45 4.01+0.75 6.42±0.36 
Lung tissue 
Control (4) 72.34+1.28 10.39+1.83 17.29±1.02 
Infected (4) 71.77±0.40 9.61±0.97 17.77±0.40 
5th week of infection 
Sediment surfactant 
Control (3) 89.88±1.50 4.10+0.69 6.04+0.81 
Infected (4) 88.28+1.20 3.67+0.40 8,05+1-00 
Lung tissue 
Control (4) 64.25+1.72 11.72+0.70 24.04+1.23 
Infected (4) 64.06+2.69 10.72+1.68 25.15±1.63 
^Number of observations. 
'^Values are meantSEM, expressed as t of total phospholipid. 
Table B5. Analysis of variance plan and observed mean squares for body weight, body weight gain, 
body temperature, heart rate, respiratory rate, oxygen consumption 
Mean squares 
sv df Body wt Body wt gain Body temp. HR RR O2 cons. 
Treatment 1 40.74 24490.96 0.04 20.44 0.20 26.17** 
Period 2 88.07 94613.84** 0.25 4936.54 18.07 1.17 
Treatment 
X period 2 18.85 1606.03 0.19 690.96 17.05 0.00 
Error 26 12.72 4093.20 0.44 780.44 7.60 0.69 
Total 31 
••Statistical significance is at P<0.01. 
Table B6. Analysis of variance plan and observed mean squares for Vy, 
^I> Vg, minute volume, alveolar ventilation, Pc, C dyn, Rft, 
WK , WK 
Mean squares 
sv df VT Vl *5 
Minute 
volume 
Treatment 1 30576.69*^ 162.30 404.52^* 11307677.85^^ 
Period 2 1850.70 9.28 5.99 1023794.10 
T reatment 
X period 2 896.30 16.14 15.38 591633.80 
Error 26 315.82 18.12 7.71 436310.74 
Total 31 
••Statistical significance is at P<0.01. 
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Mean squares 
Alveolar 
ventilation Pg Cdyn WKi WK2 
14305174.28** 253.59** 300.14 386.03 0.029** 11.14** 
1739749.10 8.14 5.70 77.37 0.004 1.48 
521283.10 3.21 1.08 23.27 0.002 0.82 
238108.66 4.51 20.10 32.35 0.0003 0.16 
Table B7. Analysis of variance plan and observed mean squares for pH, PAO2, PACO2, HCO3, BE, CO2 
content, AO2, ACO2 
Mean squares 
SV df pH PAO2 PACO2 HCG3 BE 
CO2 
content AO2 ACO2 
Treatment 1 0.012 359.55 131.04 133.36 195.79*^ 157.18 598.07 501.98^ 
Period 2 0.001 18.20 30.46 14.68 17.27 19.01 324.12 101.92 
Treatment 
X period 2 0.0001 3.56 0.00 0.00 0.00 0.00 203.96 54.42 
Error 26 0.005 65.19 19.85 13.85 9.76 14.15 84.81 28.82 
Total 31 
•Statistical significance is at P<0.05. 
••Statistical significance is at P<0.01. 
Table B8. Analysis of variance plan and observed mean squares for Hb, PCV, RBC, WBC, neutrophils, 
monocytes, eosinophils, basophils 
Mean squares 
SV df Hb PCV RBC WBC Neut. Lymph. Mono. Eosin. Baso. 
Treatment 1 2.65 29.39 0.03 98.87 314.64 611.24 5.27 0.30 0.23 
Period 2 8.97 24.-3 3.63 15.96 7.73 25.23 3.75 0.91 0.30 
Treatment 
X period 2 0.23 7.63 0.26 3.50 21.08 14.19 0.62 1.45 0.00 
Error 26 0.84 6.83 1.02 7.63 146.36 132.53 2.75 1.19 0.57 
Total 31 
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Table B9. Analysis of variance plan and observed mean squares for the 
amount of sediment, supernatant, and total lung surfactant 
from 1 liter of lavage fluid 
Mean squares 
sv df Sediment Supernatant 
Total lung 
surfactant 
Treatment 1 26208.95** 289341.25** 489714.86** 
Period 2 2491.20 3868.06 167.16 
Treatment 
X period 2 1198.70 2491.06 2878.96 
Error 26 1041.87 8853.40 12220.91 
Total 31 
••Statistical significance is at P<0.01. 
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Table BIO. Analysis of variance plan and observed mean squares for per­
cent of protein in sediment, supernatant, total lung sur­
factant, and plasma protein 
Mean squares 
sv df Sediment Supernatant Lung 
Plasma 
protein 
Treatment 1 56.29 5169.24** 0.17 7.53** 
Period 2 7.55 193.49 1.28 0.05 
Treatment 
X period 2 63.88 107.22 0.51 0.17 
Error 26 37.86 48.05 0.76 0.08 
Total 31 
••Statistical significance is at P<0.01. 
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Table BTl. Analysis of variance plan and observed mean squares for per­
cent total lipid of sediment, supernatant, total lung sur­
factant, and phospholipid content (mg/gm dry matter) of 
Mean squares 
sv df Sediment Supernatant Lung 
Lipid-P 
Sediment 
Lipid-P 
lung 
Treatment 1 82.19 2397.34** 1.48 9618.04 970.06 
Period 2 25.23 3.05 4.38 550.15 139.73 
T reatment 
X period 2 57.93 4.72 1.61 1085.49 429.39 
Error 26 41.59 33.59 4.31 1447.07 222.57 
Total 31 
••Statistical significance is at P<0.01. 
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Table B12. Analysis of variance plan and observed mean squares for 
sialic acid concentration in sediment, supernatant, total 
pulmonary surfactant, lung tissue, plasma 
Mean squares 
sv df 
Sediment 
<.08 Supernatant 
Total 
surfactant Lung Plasma 
Treatment 1 195.92 9156.15** nozQ.n** 0.01 88.99 
Period 2 18.39 124.43 168.23 0.39 86.90 
T reatment 
X period 2 35.14 125.90 298.33 0.14 23.89 
Error 26 13.75 306-83 371.14 0.17 49.70 
Total 31 
••Statistical significance is at P<0.01. 
Table B13. Analysis of variance plan and observed mean squares for body wt, lung wt, Na+, K^, CI", 
glucose, BUN, cholesterol 
Mean squares 
sv df Body wt Lung wt Na+ K+ ci- Glucose BUN Cholesterol 
Treatment 1 0.21 316.40 5.06 0.20 0.06 5.06 121.00** 95.06 
Period 1 8.73 3.85 33.06 0.01 0.56 280.56 20.25 10.06 
Treatment 
X period 1 67.08 0.19 22.56 0.36 1.56 150.06 12.25 76.56 
Error 12 18.15 36.69 8.19 0.10 . 3.40 92.94 2.96 35.31 
Total 15 
••Statistical significance is at P<0.01. 
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Table B14. Analysis of variance plan and observed mean squares for the 
radioactivity of in blood, lung tissue, sediment 
Mean squares 
sv df Blood Lung tissue Sediment 
Treatment 1 18.06 286760.25* 286225.00 
Period 1 69.03 11250.00 2450.00 
T reatment 
X period 1 3.78 6670.13 61425.13 
Error 12 2673.77 10295.71 149434.04 
Total 15 
•Statistical significance is at P<0.05. 
